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ABSTRACT 
The prevalence of infertility, the inability to conceive for 2:12 months, ranges 
from 4-16% in developed countries. We evaluated determinants of fertility impairment 
and recall error in time-to-pregnancy (TTP) among Danish pregnancy planners 
participating in a prospective cohort study. 
Study 1 examined the associations of active and passive smoking with 
fecundability-the probability of conception in a menstrual cycle given unprotected 
sexual intercourse-in 3,773 current, former, and never smokers by estimating 
fecundability ratios (FR) and 95% confidence intervals (CI). Compared with never 
smokers, fecundability was reduced among current smokers who smoked 2:10 years 
(FR=0.85, 95% CI: 0.72, 1.00) and among former smokers who had smoked 2:10 pack-
years (FR=0.74, 95% CI: 0.60, 0.92). Among never smokers, the FRs were 1.04 (95% 
CI: 0.89, 1.21) for passive smoking in early life and 0.92 (95% CI: 0.82, 1.03) for passive 
smoking in adulthood. 
Study 2 included 910 women with one previous singleton live birth and examined 
the association between previous caesarean section (CS) and fecundability. We obtained 
Vl 
data on prior delivery and obstetric complications via linkages to national registries. 
Fecundability was not reduced among women who had an emergency CS for an infant in 
cephalic presentation (FR=0.99, 95% CI: 0.80, 1.22 relative to spontaneous vaginal 
delivery). The FR was 0.72 (95% CI: 0.53, 0.97) among women who had a CS for an 
infant in breech presentation and 0.51 (95% CI: 0.25, 1.02) among women who had an 
elective CS for an infant in cephalic presentation. 
Study 3 assessed recall error among 425 women who reported their TTP during 
the fust trimester of the study pregnancy. Recall error, the difference in retrospective and 
prospective reports of TTP, ranged from -9 to 3 months, with a mean of -0.11 months 
(95% CI: -0.25, -0.04). Women with TTP>2 had greater recall error than women with 
TTP:S2. Incorporating recall error into a quantitative bias analysis of last contraceptive 
method and fecundability produced similar point estimates but wider confidence 
intervals, compared with the results from the retrospective reports. 
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1. INTRODUCTION 
The clinical definition of infertility is a 12-month or greater delay in conception. 
At a given point in time, infertility affects approximately 4-16% of couples who wish to 
have a child in well-developed countries (1). The estimated costs associated with 
diagnosing and treating infertility, and its sequelae, exceeded $5 billion in the United 
States in 2008 (2). Infertility is a consequence of dysfunction in any one of the many 
anatomical and physiological features that are required to establish a viable pregnancy, 
including gamete production and transport, fertilization, zygote transport, and 
implantation. 
Prospective cohort studies of pregnancy planners collect data on numerous 
exposures that could influence reproduction and evaluate the associations between these 
exposures and the probability of achieving pregnancy per menstrual cycle. The design 
allows for accurate and detailed data collection of time-varying exposures and precise 
measurement oftime-to-pregnancy (TTP). Investigations of many associations can be 
made with adequate validity and precision using data from several hundred to several 
thousand participants for an average follow-up time less than six months. 
The Snart Gravid study enrolled over 6,000 women who were planning a 
pregnancy in Denmark, 2007-2012, using Internet-based questionnaires (3). Internet 
access was widespread at that time in Denmark ( 4), and more pregnancies were planned 
compared with the US (5). The study was able to link questionnaire data to data from 
national registries, including the National Patient Registry and Medical Birth Registry. 
The first two studies in this dissertation aim to improve upon previous etiologic studies of 
2 
fecundability with regard to validity of exposure and outcome data and precision of effect 
estimates. The first study examines the extent to which exposure to active and passive 
smoking was associated with fecundability-the probability of conception in a menstrual 
cycle given unprotected sexual intercourse-among 3,773 current, former, and never 
smokers by estimating fecundability ratios (FR) and 95% confidence intervals (CI). The 
second study assesses the extent to which fecundability differed between women who had 
delivered their first child by caesarean section (CS) as compared with spontaneous 
vaginal delivery. The objective of the third study is to add to what is known about recall 
error ofTTP in studies that use retrospectively-measured TTP. This study quantifies the 
recall error in TTP reported by 425 women during the first trimester and demonstrates 
how to use this estimate of the recall error to correct retrospectively-measured TTP and 
obtain an effect estimate that is not biased by recall error. 
Each study is reported in the form of a manuscript suitable for submission to a 
peer-reviewed journal. Technical appendices include additional information on the data 
analyses. 
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2. ACTIVE AND PASSIVE SMOKING AND FECUNDABILITY AMONG 
DANISH PREGNANCY PLANNERS 
NOTICE: This is the author's version of a work that was accepted for publication 
in Fertility and Sterility. Changes resulting from the publishing process, such as 
peer review, editing, corrections, structural formatting, and other quality control 
mechanisms may not be reflected in this document. Changes may have been made 
to this work since it was submitted for publication. A definitive version was 
subsequently published in FERTILITY AND STERILITY, VOLUME 102, ISSUE 
1, JULY 2014 DOI:10.1016/j.fertnstert.2014.03.018. 
2.1 ABSTRACT 
Background: Tobacco smoke may have persistent effects on female reproductive 
physiology. Previous studies established an inverse dose-response relation between 
current intensity of smoking and fecundability, but they have not examined the effects of 
past intensity or cumulative exposure. Studies of current and past exposure to passive 
smoking found mixed results. Methods: We investigated the extent to which 
fecundability is associated with active smoking, time since smoking cessation, and 
passive smoking. In a prospective cohort study in Denmark, 2007-2011, 3,773 female 
pregnancy planners aged 18-40 years reported their current and past exposure to active 
and passive smoking on a baseline questionnaire. Self-reported pregnancy was elicited 
on follow-up questionnaires every two months for up to 12 months. Fecundability ratios 
(FR) and 95% confidence intervals (CI) were estimated using a proportional probabilities 
5 
model that adjusted for menstrual cycle at risk and potential confounders. Results: 
Among current smokers, smoking duration 2:1 0 years was associated with reduced 
fecundability compared with never smokers (FR=0.85, 95% CI: 0.72-1.00). Former 
smokers who had smoked 2:10 pack-years had reduced fecundability regardless of when 
they quit smoking (1-1.9 years FR=0.83, 95% CI: 0.54-1.27; 2:2 years FR=0.73, 95% CI: 
0.53-1.02). Among never smokers, the FRs were 1.04 (95% CI: 0.89-1.21) for passive 
smoking in early life and 0.92 (95% CI: 0.82-1.03) for passive smoking in adulthood. 
Conclusions: Among Danish pregnancy planners, cumulative exposure to active 
cigarette smoking was associated with delayed conception among current and former 
smokers. Time since smoking cessation and passive smoking were not appreciably 
associated with fecundability. 
2.2 INTRODUCTION 
Tobacco smoke constituents demonstrate acute effects on female reproductive 
physiology, including damaging the oocyte (1, 2) and altering concentrations of 
endogenous hormones (3-9). In addition, smoking may have persistent effects (10-13) by 
depleting the ovarian reserve (14, 15) and increasing susceptibility to sexually transmitted 
infection (16-18). 
Epidemiologic studies have consistently shown an inverse association between 
intensity of current smoking and fecundability (19), defined as the cycle-specific 
probability of conception among non-contracepting couples. Studies of former smokers 
have not found reduced fecundability (20-22) or an increased risk of infertility (16, 23) 
relative to never smokers, implying that the effect of smoking on fecundability does not 
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persist. However, these studies did not use information on the amount or duration of 
smoking among the former smokers, which may have obscured possible tobacco effects 
with high cumulative levels of exposure (19, 24). With regard to prenatal exposure to 
tobacco smoke, studies of fecundability in relation to in utero exposure to maternal 
smoking are mixed, with some showing an inverse association (22, 25, 26) and others 
showing little association (27-29). 
We examined the association of cumulative exposure to active smoking with 
fecundability among both current and former smokers in a prospective cohort study of 
pregnancy planners in Denmark. In addition, we assessed the association between 
cumulative exposure to smoking and fecundability among former smokers in sub-groups 
of time since cessation. Among never smokers, we assessed the extent to which 
exposure to passive smoking during various life stages (in utero or in childhood; 
adolescence; and adulthood) was associated with reduced fecundability. 
2.3 MATERIALS AND METHODS 
Study Population 
The Snart-Gravid study enrolled women in Denmark aged 18-40 years who were 
planning a pregnancy during 2007-2011. Eligible participants were in a stable 
relationship with a male partner, not using fertility treatments, and willing to provide 
their identification number from the Danish Civil Registration System and email address 
(30). The study used Internet-based questionnaires to obtain informed consent and self-
reported exposure and outcome data (31 ). The study protocol was approved by the 
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ethical review boards of Boston University Medical Center and the Danish Data 
Protection Board (J. no. 2010-41-4345). 
Assessment of Exposure 
Participants reported their current smoking habits and history of active and 
passive smoking exposure on the baseline questionnaire. Current smokers were 
categorized as regular smokers if they smoked at least one cigarette per day and 
occasional smokers if they smoked less. Regular smokers reported the current intensity 
in categories of cigarettes smoked per day (1-4, 5-9, 10-19, 20-29, and 2:30), the age they 
started, and the number of years they had abstained from smoking. Former smokers 
reported the average number of cigarettes smoked per day in the same categories, the 
ages when they started and stopped, and the duration of smoking in years. Participants 
reported their history of passive smoking exposure as the average number of hours per 
day during the following ages: 0-10, 11-20, 21-30, and 31-40 years. The questionnaire 
also asked participants about their exposure in utero: "Did your mother smoke cigarettes 
while she was pregnant with you?" 
Assessment of Covariates 
The baseline questionnaire included information on female age, height and 
weight, education, household income, occupation, reproductive and medical histories, 
and lifestyle habits such as frequency of intercourse, consumption of alcoholic and 
caffeinated beverages, and physical activity. Participants reported whether they had daily 
or near-daily exposure to the following environmental hazards at home or at work: 
agricultural pesticides; metal particulates or fumes; solvents, oil-based paints, or cleaning 
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compounds; environments with temperatures >25° C; chemotherapeutic drugs; engine 
exhaust; chemicals for hair dyeing, straightening, or curling; chemicals for manicure and 
pedicure. Females also reported information on their male partner' s age, height and 
weight, smoking habits and history, and exposure to environmental hazards. 
Assessment of Pregnancy and Cycles at Risk 
On bi-monthly follow-up questionnaires, participants reported whether they had 
conceived and, if so, whether the pregnancy was confirmed by a home pregnancy test or 
a clinician. Total menstrual cycles at risk were calculated from participants' reported 
number of months spent trying to conceive at the time of enrollment, date of last 
menstrual period (LMP) before enrollment, usual menstrual cycle length, and LMP date 
on each follow-up questionnaire (32). A participant contributed menstrual cycles from 
the time she enrolled until she reported a confirmed pregnancy or was censored. 
Censoring occurred if the woman initiated fertility treatment, was no longer attempting 
pregnancy, withdrew from the study, was lost to follow up, or completed 12 cycles from 
the beginning of her attempt to conceive, whichever came first. 
Exclusions 
From June 2007 through December 2011 , 5,921 eligible women enrolled. We 
excluded 297 women (5%) with incomplete or implausible information about their LMP 
date or the start date of their pregnancy attempt; 580 women (10%) who did not fill out a 
follow-up questionnaire; 1,153 women (20%) who had attempted pregnancy for >6 
cycles at baseline; and 118 women (2%) who reported smoking cessation <1 year ago 
(because of uncertainty of the timing of smoking cessation with respect to the start of the 
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pregnancy attempt). After these exclusions, 3,773 women were included in the present 
analysis. The 475 women (13%) subsequently lost to follow-up (mean follow-up time= 
3.3 months) were on average younger (27.9 vs. 28.4 years), heavier (BMI: 25.1 vs. 24.0 
kg/m2), less educated (2:4 years of vocational training: 50% vs. 59%), and more likely to 
be parous (3 3% vs. 28% ), regular smokers ( 18% vs. 11%) and exposed to passive 
smoking in adulthood (42% vs. 34%) than those not lost to follow-up. Similar 
proportions used oral contraceptives as their last form of birth control (61% vs. 61 %). 
Data Analysis 
We analyzed exposure to smoking among current smokers in terms of duration 
and intensity, and among former smokers, in terms of duration, intensity, pack-years, and 
time since cessation. We also assessed joint categories of these variables where 
appropriate. Never-smokers were the reference category for these analyses. Pack-years 
among current smokers depended greatly on the current intensity category; because of the 
ambiguity of whether pack-years captured current intensity of exposure or cumulative 
exposure, we did not analyze exposure among current smokers in terms of pack-years. 
We defined exposure to passive smoking as spending 2:1 hour per day in the same room 
with someone who was smoking. We categorized this exposure according to life stage: 
early life (in utero or in childhood), adolescence, adulthood, no exposure at any life stage 
(reference category). 
We estimated fecundability ratios (FR) and 95% confidence intervals (CI) for 
each category of exposure relative to the reference category. An FR < 1.0 corresponds to 
reduced fecundability among exposed relative to unexposed women. To model 
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probabilities of conception in a given cycle at risk of pregnancy, we used PROC 
GENMOD in SAS version 9.2 (33) to fit a proportional probabilities model (25). The 
proportional probabilities model differs from the Cox proportional hazards model mainly 
in that it uses discrete time to event, and it incorporates the decline of baseline 
fecundability over time with a binary indicator variable for cycle number at risk (34). 
Potential confounders were selected a priori based on a literature review and causal 
graphs. The primary analysis also modeled different types of exposure with mutual 
adjustment (e.g., active vs. passive smoking) to assess their independent effects. Results 
presented in the text were adjusted for age (18-24, 25-29, 30-34, 35-40 years), passive 
smoking in adulthood (0, 1-2, and 2:3 hours/day), and whether the male partner was a 
current, regular smoker (yes, no). Selected models were further adjusted for education 
(no vocational training, basic vocational training, 1-2 years ofhigher education, >2 years 
of higher education) because it changed the crude FR by 2:5% in models for regular 
smoker, occasional smoker, intensity in current smokers, and passive smoking. No other 
potential confounder changed the crude FR by 2:5%. Adjusting for parity strengthened 
the associations by about 5%; we did not present these results because they could be 
biased if parity is affected by both the exposure and underlying fecundity (35). We also 
computed the FR and 95% CI for smoking intensity with additional adjustment for 
duration and vice versa. The assumption of proportional probabilities was evaluated by 
examining the FRs stratified by number of cycles, in two categories: 1-5 and 6-12. 
Analyses of certain exposures in former smokers were restricted by age in order to avoid 
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sparse data problems: duration (25-40 years), duration and intensity (25-34 years), pack-
years and time since cessation (25-34 years). 
We used multiple imputation to impute missing values for exposure and 
covariates (36), producing five imputed data sets with PROC MI. For smoking 
variables, the proportions missing were as follows: duration 0.4%, intensity 1.1 %, passive 
smoke exposure in early life 1.8%, adolescence 11%, and adulthood 14%. We used 
PROC MIANAL YZE to account for the use of five imputed data sets. 
2.4 RESULTS 
The analysis included 3,773 women (474 regular smokers, 212 occasional 
smokers, 741 former smokers, and 2,346 never smokers) contributing 15,774 menstrual 
cycles and 2,578 confirmed pregnancies. 
Current Smokers 
At baseline, smoking intensity (cigarettes/day) was positively associated with 
passive smoking, BMI, use of hormonal last method of contraception, parity, gravidity, 
history of infertility, consumption of alcohol and caffeine, partner smoking, and partner 
age (Table 1 ). Participant and partner exposure to certain environmental hazards were 
also positively associated with smoking: solvents, oil-based paints, and detergents; high 
temperature environments; and, for the partner only, metal particulates and fumes. 
Intensity was inversely associated with female age, education, and household income. 
Compared with never smokers, the FR for regular smokers was 0.89 (95% CI: 
0.77-1.03) and the FR for occasional smokers was 1.11 (95% CI: 0.95-1.25) (Table 2). 
The FRs for the four levels of smoking intensity, 1-4, 5-9, 10-19, and ~20 cigarettes/day, 
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were 1.01 (95% CI: 0.78-1.32), 0.86 (95% CI: 0.70-1.07), 0.86 (95% CI: 0.71-1.05) and 
0.84 (95% CI: 0.55-1.29). Further adjustment for duration of smoking attenuated the 
association between smoking intensity and fecundability by :S5% in each of the upper 
three levels of smoking intensity (Table 3). 
The association of smoking duration with fecundability appeared to depend on 
intensity. Duration of smoking among regular smokers was inversely associated with 
fecundability (<10 years FR=0.92, 95% CI: 0.74-1.14; 2:10 years FR=0.85; 95% CI: 0.72-
1.00) (Table 2). Smoking 2:10 cigarettes/day was associated with reduced fecundability 
among those with both short and long durations of smoking ( <1 0 years: FR=0.81 , 95% 
CI: 0.60-1.10; 2:10 years: FR=0.82, 95% CI: 0.66-1.01). However, among participants 
who smoked <10 cigarettes/day, we observed appreciable adverse effects on 
fecundability only with greater duration of smoking ( 1-4 cigarettes/day and <1 0 years, 
FR=0.99, 95% CI: 0.66-1.49; 1-4 cigarettes/day and 2:10 years duration, FR=0.91 , 95% 
CI: 0.65-1.27; 5-9 cigarettes/day and <10 years duration FR=0.95, 95% CI: 0.69-1.31 ; 5-
9 cigarettes/day and 2:10 years duration FR=0.76, 95% CI: 0.58-0.99). 
Former Smokers 
Among former smokers, time since cessation was positively associated with age 
at baseline (Table 1). Former smokers who had quit 1-1.9 years ago were less likely to 
be parous, more likely to be passive smokers in adulthood and exposed to partner 
smoking, and more likely to report exposure to environmental hazards than never 
smokers. 
Fecundability among former smokers was similar to that of never smokers 
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(FR=0.99, 95% CI: 0.90-1.08) (Table 4). The FRs for the four levels of smoking 
intensity, 1-4, 5-9, 10-19, and 2':20 cigarettes/day, were 0.88 (95% Cl: 0.75-1.05), 1.13 
(95% CI: 0.97-1.32), 1.04 (95% CI: 0.90-1.19) and 0.92 (95% Cl: 0.71-1.19). No trend in 
fecundability was found when former smokers were grouped by both intensity and time 
since cessation. 
Relative to never smokers, the FR for having smoked < 1 0 years was 1.10 (95% 
CI: 0.99-1.23) and the FR for having smoked 2':10 years was 0.89 (95% CI: 0.75-1.04) in 
women age 25-40. The FRs for smoking duration 2':1 0 years in women age 25-34 who 
had smoked 1-4, 5-9, 10-19 and 2':20 cigarettes/day were: 0.85 (95% CI: 0.59-1.23), 0.96 
(95% CI: 0.71-1.31), 0.84 (95% CI: 0.65-1.08) and 0.80 (95% CI: 0.54-1.18). High 
cumulative exposure to smoking (2': 10 pack-years) was associated with reduced 
fecundability, regardless oftime since smoking cessation (2':10 pack-years and 1-1.9 years 
since cessation: FR=0.83 , 95% CI: 0.54-1.27; 2': 10 pack-years and 2':2 years since 
cessation: FR=0.73 , 95% CI: 0.53-1.02). 
Passive Smoking 
Passive smoking exposure in adulthood was positively associated with partner 
regular smoking (Table 6). Passive smoking exposure at all life stages was positively 
associated with participant and partner BMI, use of hormonal last method of 
contraception, parity, and exposure to environmental hazards; it was inversely associated 
with education (Table 7). 
Among never smokers, passive smoking in adulthood was slightly associated with 
reduced fecundability, whether the participant was exposed for 1-2 or 2':3 hours/day (1-2 
14 
hours/day FR=0.92, 95% CI: 0.81-1.04; 23 hours/day FR=0.92, 95% CI: 0.73-1.14) 
(Table 8). Having a partner who was a current or former smoker was not associated with 
reduced fecundability (data not shown). Stratified by partner' s smoking status, FR=1.01 , 
95% CI: 0.83-1.22 if the partner was a regular smoker, and FR=0.90, 95% CI: 0.79-1.02 
if not. 
Never smokers exposed to passive smoking in earlier life stages had similar 
fecundability to those with no exposure to passive smoking at any life stage (early life 
only FR=1.04, 95% CI: 0.89-1.21; adolescence only FR=0.97, 95% CI: 0.72-1.32; early 
life and adolescence FR=1.01 , 95% CI: 0.90-1.13). The FR for exposure to smoking in 
utero was also similar to that for exposure in early life (FR= 1.01 , 95% CI: 0.92-1.11). 
2.5 DISCUSSION 
In this prospective study of pregnancy planners, high cumulative exposure to 
active smoking was associated with reduced fecundability in both current and former 
regular smokers relative to never smokers. Among former smokers, more recent (1 year 
ago) and more distant quitters (22 years ago) had similar reductions in fecundability. 
Current intensity of regular smoking (2 10 cigarettes/day; among smokers with duration 
2 10 years, 25 cigarettes/day) was associated with reduced fecundability relative to never 
smokers. Exposure to passive smoking in early life, adolescence, and adulthood was not 
materially associated with fecundability among never smokers. 
Studies with exposure and outcome definitions similar to ours reported a 
stronger inverse association between current smoking 220 cigarettes/day and 
fecundability, with FRs ranging from 0.57 to 0.78 (37) (21) (20). We found an 
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association between smoking 5-9 cigarettes/day and reduced fecundability that was 
similar in magnitude to that observed in the higher exposure categories, and this 
association was only present among smokers with 2:10 years duration. Previous studies 
of the association between smoking 5-9 cigarettes/day and fecundability reported weakly 
inverse (38) or null (20, 21) associations. It is possible that under-reporting of smoking 
by heavy smokers in our study led to exaggerated effects on fecundability for light 
smoking, although we have no evidence for this type of misclassification. Women who 
were occasional smokers had an 11% increase in fecundability relative to never smokers, 
but there were comparatively few women who were occasional smokers. Previous 
studies reported little difference in fecundability among light regular smokers versus non-
smokers (20, 21). 
Our study found that former smokers with high cumulative exposure (2:10 pack-
years) had reduced fecundability, although former smokers as a group had no appreciable 
difference in fectmdability compared with never smokers. Prior studies show that former 
smokers have similar fecundability to never smokers (20-22), even within one year of 
cessation (20, 22), but these studies did not separate out heavy from light smokers. Other 
studies among former smokers showing that greater pack-years of smoking was 
associated with reduced ovarian function among women undergoing assisted 
reproductive technology (14), and with shorter cycle length (39), a correlate of reduced 
fecundability ( 40-43 ). 
Among women with no history of active smoking, passive smoking in adulthood 
appeared to have little effect on fecundability. Exposure misclassification may have 
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attenuated the relation between current passive smoking exposure and fecundability, if 
exposure during the menstrual cycle at risk is the biologically relevant exposure ( 44, 45). 
The questionnaire asked about hours per day of passive smoking exposure during the 
current decade of age, which could easily differ from the exposure during the current 
menstrual cycle ( 46). The literature on this relation is mixed, possibly due to differences 
in exposure definition and measurements (44). Passive smoking was associated with 
time-to-pregnancy>6 months among non-smokers in one study (47). Non-smokers 
exposed to passive or partner smoking had a modest increased risk of implantation failure 
following in vitro fertilization (1 0%-17%) in some ( 44, 48, 49) but not all studies (50, 
51). Our finding that partner smoking was not associated with reduced fecundability is in 
agreement with a meta-analysis of four studies (24). Other studies found that partner 
smoking was associated with reduced fecundability (20, 22, 52) and early pregnancy loss 
(53), which could manifest as reduced fecundability. 
The current study is the largest prospective study of passive smoking in early life 
and fecundability, adding to evidence against a large adverse effect on future fertility. In 
utero exposure to maternal smoking was associated with reduced fecundability (FRs in 
the range from 0.53 to 0.81) in two prospective cohort studies (22, 25) and one 
retrospective cohort study (26), while the association was nearly null in three 
retrospective cohort studies (FRs in the range from 0.96 to 1.02) (27-29). These studies 
ascertained exposure as we did, except for one study that used the subject' s mother' s self-
report after delivery to ascertain exposure and found no association (28). 
17 
Regular smokers were more likely to be lost to follow up than never smokers. If 
the smokers who were lost to follow up were more likely to get pregnant than those who 
remained in the cohort, our results would have overestimated the inverse association. 
Another methodological consideration is the extent to which the inverse association of 
cumulative exposure to smoking and fecundability is overestimated as a result of the 
study's recruitment of pregnancy planner volunteers. This volunteer cohort could 
exclude smokers who are highly fertile, since smokers may be more likely to have 
unplanned pregnancies (37). Baird and Wilcox demonstrated via simulation that this 
exclusion by itself would result in smoking FR=0.91, assuming that 30% of pregnancies 
were accidental (37). This is less of a problem in our study because unplanned 
pregnancies are relatively rare in Denmark (54, 55). When we restricted the analyses to 
participants who had tried to conceive :S 2 cycles at enrollment, our results were 
essentially unchanged (Regular smoker FR=0.86, 95% CI: 0.72-1.02; former smoker 2:10 
pack-years FR=0.83 , 95% CI: 0.63-1.10). 
We were able to adjust for numerous potential confounders. After first adjusting 
for age, there was little difference in the observed associations with further adjustment for 
lifestyle, reproductive, environmental, and medical factors. There may have been 
confounding from factors that we did not measure, e.g., unhealthy diet (56) or 
asymptomatic pelvic inflammatory disease (57). We assessed exposure to environmental 
hazards with self-report from a check-list of broad categories; any misclassification 
resulting from this method would have limited our ability to adjust for confounding by 
environmental hazards. 
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The female participants may have been motivated to participate in an Internet-
based study of time-to-pregnancy, but we would not expect this to limit generalizability. 
The biologic relation of smoking exposure and fecundability should not be affected by 
Internet use and study participation. 
The cumulative amount of active smoking may be related to the degree of 
persistent harm to certain processes necessary for reproduction. First, cigarette smoke 
may accelerate ovarian depletion. Polycyclic aromatic hydrocarbons (PAH), which are 
found in cigarette smoke, were detectable in the granulosa cells and follicular fluid of 
smokers ( 11 ). In vitro studies have found that toxicological concentrations of P AH 
induce apoptosis in primordial oocytes (1 , 2). However, women treated with low toxicity 
chemotherapy regained pretreatment levels ofanti-Mullerian hormone (AMH), an 
indicator of ovarian reserve (58), within six months (59). Even if ovarian toxicants such 
as tobacco smoke affect only the ovarian follicles that are growing, they may shorten the 
follicular phase, thereby shortening the menstrual cycle and increasing the rate of follicle 
recruitment (15). Animal studies of exposure to P AH at doses consistent with those 
from active smoking have found that benzo[a]pyrene inhibits follicle growth in vitro (60), 
while cigarette smoke exposure in vivo significantly decreases the number of primordial 
follicles without increasing the rate of apoptosis (15) . However, the evidence from 
epidemiologic studies of ovarian aging comparing former with never smokers is 
uncertain. Age at natural menopause among former smokers was either slightly lower 
(61, 62) or similar (63 , 64) to what it was in never smokers. Serum AMH concentrations 
were lower among current smokers (65-67) but not former smokers (65). These studies 
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may also have missed an effect from 2:10 pack-years if that is required for accelerated 
ovarian depletion. We evaluated the evidence of this biological pathway indirectly by 
stratifying the association of 2:10 pack-years and fecundability among former smokers by 
age. The association was somewhat stronger among women age2:35 years than in women 
age<3 5 years, suggesting that this biological pathway may be operating in our population 
(multivariable-adjusted FR=0.62, 95% CI: 0.35-1.11 among women aged2:35 years; 
FR=0.78, 95% CI: 0.60-1.02 among women aged<35 years). 
Second, smoking may impair tubal function and increase susceptibility to 
ascending infection (68). These impairments include reduced muscular contraction, cilial 
beat frequency, and blood flow, demonstrated in animal models (10, 12, 69-71). Poorer 
systemic immune responses in smokers have also been observed; for example, less 
lymphocyte response to T -cell mitogens (72, 73), less leukocyte chemotaxis and 
migration (74), and lower titers of influenza antibodies (72). Case-control studies found 
that current smokers were at an increased risk for pelvic inflammatory disease ( 17, 18) 
and tubal factor infertility (16) compared with never smokers. However, only one of 
these studies also found an increased risk in former smokers (17). In our data, the age-
standardized prevalence of self-reported history of pelvic inflammatory disease was 14% 
among never smokers and 14%, 19%, and 23% among former smokers with <5, 5-9, and 
2: 10 pack-years of smoking, respectively. 
In conclusion, we found that women with high cumulative exposure to active 
smoking had reduced fecundabi1ity. This fmding was apparent in current smokers as well 
as in former smokers, with similar reductions in fecundability among more recent and 
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more distant quitters. Passive smoking in early life, adolescence, and adulthood did not 
have a strong effect on fecundability. Our data support the theory that heavy, prolonged 
exposure to regular active smoking increases the risk of persistent damage to female 
fertility, apart from the established acute effect. 
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Table 1. Baseline characteristics of 3, 773 women age 18-40 years according to smoking status: The Snart-Gravid Cohort, Denmark, 
2007- 20 ll.a 
Never Current smoker: Former smoker: time 
Smoker number of cigarettes/day since cessation, years 
<1 1-4 5-9 10-19 >20 1-1.9 >2 
Number of women 2,346 212 70 146 223 35 135 606 
Participant's age, years (mean) 28.3 28.0 28.1 26.9 27.3 27.5 28.4 29.9 
Male Partner's age, years (mean) 30.8 30.5 29.6 30.9 31.5 32.3 30.9 31.2 
Smoking duration, years (mean) 0 I 0.1 11.8 12.0 12.5 13 .7 I 0.5 7.1 
Partner is a regular smoker(%) 11 23 58 60 71 76 16 12 
Passive smoking exposure in adulthood(%) 23 49 56 72 83 80 52 36 
Participant's mother smoked while pregnant(%) 34 29 30 43 55 66 35 35 
Intercourse frequency 2::4/week (%) 18 16 24 26 29 21 20 17 
Doing something to time intercourse(%) 46 46 45 43 46 45 49 49 
Body mass index of participant, kg/m2 (mean) 24.0 23.7 24.4 24.4 25 .2 25.2 24.4 24.4 
Body mass index of partner, kg/m2 (mean) 
N 
25.3 25.0 25.8 26.3 26.0 26.0 25 .3 25 .6 -....J 
Last contraceptive method: hormonalb (%) 63 64 65 60 64 81 68 57 
Parous(%) 31 27 41 43 40 32 21 44 
Ever pregnant (%) 41 44 56 66 57 67 39 54 
History of infertility(%) 8 7 15 14 13 13 11 9 
History of pelvic inflammatory disease(%) 14 15 21 20 25 40 15 17 
Regular cycles (%) 76 74 80 76 84 78 74 74 
No vocational training or higher education(%) 10 10 11 18 27 25 13 11 
Household income <25,000 Danish Kroner/yr (%) 13 18 14 17 16 33 14 11 
Participant exposure to environmental hazards(%) 17 19 19 22 29 25 26 18 
Partner exposure to environmental hazards(%) 22 24 31 34 39 45 30 28 
Caffeine intake, mg/day (mean) 108 170 141 184 239 322 160 160 
Consumes >7 alcoholic bevera!;1ies/week (%) 8 26 26 10 18 23 16 12 
a All characteristics except age are age-standardized to the distribution of the cohort at baseline. 
b Includes oral contraceptive pills and other hormonal contraceptives such as patch and injection. 
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Table 2. Current active smoking exposure in relation to fecundability in 3,302 women: 
The Snart-Gravid Cohort, Denmark, 2007-2011 . 
Never smoker 
Current occasional smoker 
Current regular smokerc 
Intensity, cigarettes/dal 
1-4 
5-9 
10-19 
~ 20 
Duration, years 
< 10 
~ 10 
Intensity and Durationd 
1 - 4 cigarettes, < 1 0 years 
1 - 4 cigarettes, ~ 10 years 
5 - 9 cigarettes, < 10 years 
Pregnancies 
1,626 
153 
288 
49 
87 
132 
20 
99 
189 
20 
29 
35 
5 - 9 cigarettes, ~ 10 years 52 
~ 10 cigarettes, < 10 years 44 
~ 10 cigarettes, ~ 10 years 108 
FR = Fecundability Ratio, CI=Confidence Interval. 
Cycles 
9,709 
826 
2,174 
313 
675 
1,026 
160 
743 
1,431 
116 
197 
251 
424 
376 
810 
Model 1 
FR(95% Cit 
1.00 (ret) 
1.07 (0.93-1.25) 
0.82 (0.73-0.92) 
0.94 (0.73-1.22) 
0.80 (0.65-0.97) 
0.81 (0.69-0.95) 
0.76 (0.50-1.15) 
0.82 (0.68-0.99) 
0.82 (0.72-0.95) 
1.00 (0.67 -1.49) 
0.90 (0.64-1.26) 
0.85 (0.63-1.16) 
0. 76 (0.59-0.99) 
0.73 (0.55-0.97) 
0.83 (0.70-1.00) 
a Model 1 FR and 95% CI are adjusted for cycle number at risk. 
Model2 
FR (95% CI)b 
1.00 (ret) 
1.11 (0.95-1.25) 
0.89 (0.77-1.03) 
1.01 (0.78-1.32) 
0.86 (0.70-1.07) 
0.86 (0. 71-1.05) 
0.84 (0.55-1.29) 
0.92 (0.74-1.14) 
0.85 (0. 72-1.00) 
0.99 (0.66-1.49) 
0.91 (0.65-1.27) 
0.95 (0.69-1.31) 
0.76 (0.58-0.99) 
0.81 (0.60-1.1 0) 
0.82 (0.66-1.0 1) 
b Model2 FR and 95% CI are adjusted for cycle number at risk, age, partner smoking, and 
passive smoking. 
c Model 2 FR and 95% CI are also adjusted for education. 
d The FRs and 95% Cis for the combination of intensity and duration were computed from a 
model that did not include terms for the main effects of intensity and duration. 
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Table 3. Fecundability among 474 regular smokers and 741 former smokers 
relative to that among 2,346 never smokers: 
The Snart-Gravid Cohort, Denmark, 2007-2011. 
Pre~nancies Cycles FR(95% Cl) 
Never smoker 1,626 9,709 1.00 (ref) 
Current regular smoker 288 2,174 
Intensity, cigarettes/da/ 
1-4 49 313 1.04 (0.79-1.37) 
5-9 87 675 0.88 (0.71-1.10) 
10-19 132 1,026 0.89 (0.72-1.09) 
2:20 20 160 0.88 (0.57-1.37) 
Duration, yearsb 
< 10 99 743 0.90 (0.70-1.17) 
2: 10 189 1,431 0.85 (0.69-1.04) 
Former smoker 511 3,065 
Intensity, cigarettes/dayc 
1-4 126 864 0.84 (0.70-1.00) 
5-9 157 798 1.11 (0.95-1.29) 
10-19 178 1,054 1.07 (0.93-1.24) 
2:20 50 349 1.00 (0.76-1.30) 
Duration, yearsd 
< 10 280 1,506 1.10 (0.94-1.27) 
2: 10 177 1,271 0.89 (0. 76-1.05) 
a FR and 95% CI are adjusted for cycle number at risk, age, partner smoking, passive smoking, 
education, and duration--set to the modal category, nine years. 
b FR and 95% CI are adjusted for cycle number at risk, age, partner smoking, passive smoking, 
education, and intensity--set to the modal category, 10-19 cigarettes per day. 
c FR and 95% CI are adjusted for cycle number at risk, age, partner smoking, passive smoking, 
and duration--set to the modal category, eight years. 
d FR and 95% CI are adjusted for cycle number at risk, age, partner smoking, passive smoking, 
and intensity-set to the modal category, 10-19 cigarettes per day. 
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Table 4. Past active smoking exposure in relation to fecundability in 3,087 women: The 
Snart-Gravid Cohort, Denmark, 2007-2011. 
Modell Model2 
Pre~ancies C~cles FR~95% crt FR (95% CI)b 
Never smoker 1,626 9,709 1.00 (ref) 1.00 (ref) 
Former smoker 511 3,065 1.00 (0.92-1.1 0) 0.99 (0.90-1 .08) 
Time since cessation, years 
91 591 0.94 (0.78-1.14) 0.93 (0.77-1.13) 
2: 2 420 2,474 1.02 (0.92-1.12) 1.02 (0.93-1.13) 
Intensity, cigarettes/day 
1-4 126 864 0.89 (0.75-1.05) 0.88 (0.75-1.05) 
5-9 157 798 1.13 (0.97-1.31) 1.13 (0.97 -1.32) 
10-19 178 1,054 1.03 (0.89-1.18) 1.04 (0.90-1.19) 
2:20 50 349 0.90 (0.70-1.17) 0.92 (0.71-1.19) 
Duration, yearsc 
< 10 280 1,506 1.07 (0.97 -1.18) 1.10 (0.99-1.23) 
2: 10 177 1,271 0.85 (0.75-0.97) 0.89 (0.75-1.04) 
Intensity and durationd 
1-4 cigarettes, <10 years 81 517 0.92 (0.77-1.11) 0.92 (0.75-1.14) 
1-4 cigarettes, 2: 10 years 25 154 0.79 (0.57-1.10) 0.85 (0.59-1.23) 
5-9 cigarettes, <10 years 80 383 1.11 (0.94-1.32) 1.11 (0.90-1.38) 
5-9 cigarettes, 2: 10 years 36 215 0.99 (0.77-1.26) 0.96 (0.71-1.31) 
10-19 cigarettes, <1 0 years 81 388 1.16 (0.98-1.37) 1.16(0.95-1.42) 
10-19 cigarettes, 2: 10 years 56 401 0.85 (0.70-1.03) 0.84 (0.65-1.08) 
2:20 cigarettes, < I 0 years 20 70 1.18 (0.85-1.65) 1.54 ( 1.07-2.23) 
2:20 cigarettes, 2: 10 years 23 174 0.74 (0.54-1.03) 0.80 (0.54-1.18) 
Pack-years 
< 5 331 1,880 1.01 (0.91-1.12) 1.00 (0.91-1.11) 
5-9 116 640 1.08 (0.92-1.26) 1.08 (0.92-1 .27) 
2: 10 64 545 0.75 (0.61-0.93) 0.74 (0.60-0.92) 
Time since cessation and 
pack-yearse 
1 year, <10 pack-years 53 356 0.86 (0.67-1.11) 0.87 (0.67-1.12) 
1 year, 2: 10 pack-years 18 133 0.84 (0.55-1.29) 0.83 (0.54-1.27) 
2: 2 years, <10 pack-years 299 1,554 1.08 (0.96-1.21) 1.08 (0.96-1 .21) 
2: 2 years, 2: 10 pack-years 32 259 0.75 (0.54-1.05) 0.73 (0.53-1.02) 
FR= fecundability ratio; CI =confidence interval. 
a Model 1 FR and 95% CI are adjusted for cycle number at risk. 
b Model 2 FR and 95% CI are adjusted for cycle number at risk, age, partner smoking, and 
passive smoking. 
31 
c Analyzed in participants age 2:25 years at baseline. 
d The FRs and 95% Cis for the combination of intensity and duration were analyzed in 
participants age 2:25 years at baseline. The model did not include terms for the main effects of 
intensity and duration. 
e Analyzed in participants age 25-34 years at baseline. 
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Table 5 Fecundability according to smoking intensity and time since cessation in 3,087 
women: The Snart .. Gravid Cohort, Denmark, 2007-2011. 
Pregnancies Cycles Model 1 Model2 FR (95% Cl)3 FR (95% CI)b 
Never smoker 1,626 9,709 1.00 (ref) 
Former smoker 511 3,065 
Quit 1 year: 
1 - 4 20 155 0.79 (0.52-1.19) 0.87 (0.58-1.31) 
5-9 19 145 0.82 (0.54-1.24) 0.80 (0.53-1.21) 
10- 19 37 209 1.03 (0.77-1.39) 1.08 (0.80-1.45) 
2:20 15 82 1.22 (0. 78-1.92) 1.20 (0.76-1.90) 
Quit 2: 2 years: 
1 -4 106 709 0.91 (0.76-1.09) 0.91 (0. 76-1.09) 
5-9 138 653 1.19 (1.01-1.39) 1.16 (0.99-1.36) 
10- 19 141 845 1.02 (0.88-1.20) 0.99 (0.84-1.16) 
2:20 35 267 0.81 (0.60-1.11) 0.78 (0.57-1.07) 
FR= fecundability ratio; CI =confidence interval. 
a Model 1 FR and 95% CI are adjusted for cycle number at risk. 
b Model 2 FR and 95% CI are adjusted for cycle number at risk, age, partner smoking, and 
passive smoking. 
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Table 6. Baseline characteristics of 1,054 female never smokers who reported exposure to 
passive smoking for 2:1 hour per day at none or only one of the life stages under study: 
The Snart-Gravid Cohort, Denmark, 2007- 2012.a 
None Early life Adolescence Adulthood on!~ on!~ on!~ 
Number of women 591 295 59 109 
Participant's age, years (mean) 28.0 28.3 28.5 27.9 
Male Partner's age, years (mean) 30.8 30.5 30.9 31.1 
Partner is a current, regular smoker(%) 4 6 23 
Passive smoking in adulthood 2:3 hrs/day (%) 0 0 0 18 
Participant's mother smoked while pregnant 0 35 0 0 (%) 
Intercourse frequency 2:4/week (%) 17 19 12 21 
Doing something to time intercourse(%) 46 45 45 44 
Body mass index of participant, kg/m2 (mean) 23 .2 23.6 23.0 23.1 
Body mass index of partner, kg/m2 (mean) 24.9 25 .1 24.7 25.2 
Last contraceptive: hormonalb (%) 59 58 63 62 
Last contraceptive: combination hormonal(%) 59 58 63 62 
History of infertility(%) 8 7 10 10 
Parous(%) 27 31 30 23 
Ever pregnant (%) 35 38 36 36 
Regular cycles (%) 75 77 81 78 
No vocational training or higher education(%) 10 8 10 10 
Household income <25,000 Danish Kroner/year 13 13 15 14 (%) 
Participant exposure to environmental hazards 14 14 16 18 (%) 
Partner exposure to environmental hazards(%) 15 18 27 23 
Caffeine intake, mg/day (mean) 99.4 109 114 112 
Consumes 2:7 alcoholic beverages/week(%) 6 7 15 9 
"All characteristics except age are age-standardized to the distribution of the cohort at baseline. 
b Includes oral contraceptive pills and other hormonal contraceptives such as patch and injection. 
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Table 7. Baseline characteristics of 1,883 female never-smokers who reported exposure 
to passive smoking for 2:1 hour per day at either none, two, or all three of the life stages 
under study: The Snart-Gravid Cohort, Denmark, 2007- 2011.a 
Early life Early life Adolescence Exposed 
None and and and at all 
adolescence adulthood adulthood stages 
Number of women 591 858 34 59 341 
Participant's age, years (mean) 28.0 29.1 27.9 27.5 27.2 
Male Partner's age, years (mean) 30.8 30.6 31.4 30.7 30.6 
Partner is a current, regular smoker 4 6 38 28 31 (%) 
Passive smoking in adulthood 2: 3 0 0 8 27 23 hrs/day (%) 
Participant's mother smoked while 0 56 18 0 61 pregnant(%) 
Intercourse frequency 2:4/week (%) 17 19 12 16 20 
Doing something to time intercourse 46 48 34 41 44 (%) 
Body mass index of participant, 23.2 24.5 26.2 23.5 25.1 kg/m2 (mean) 
Body mass index of partner, kg/m2 24.9 25.4 25.8 25.0 25.7 (mean) 
Last contraceptive: hormonalb (%) 59 64 78 66 69 
History of infertility (%) 8 8 2 3 10 
Parous(%) 27 35 28 25 31 
Ever pregnant(%) 35 44 37 35 45 
Regular cycles (%) 75 74 78 80 75 
No vocational training or higher 10 10 14 10 13 
education(%) 
Household income <25,000 Danish 13 13 16 22 14 Kroner/year (%) 
Participant exposure to 14 18 16 19 22 
environmental hazards (%) 
Partner exposure to environmental 15 24 28 37 30 hazards(%) 
Caffeine intake, mg/day (mean) 99.4 111 90.3 102 115 
Consumes 2:7 alcoholic 6 8 10 7 9 beverases/week (%) 
a All characteristics except age are age-standardized to the distribution of the cohort at baseline. 
b Includes oral contraceptive pills and other hormonal contraceptives such as patch and injection. 
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Table 8. Exposure to passive smoking in relation to fecundability in 2,346 women with 
no history of active smoking: The Snart-Gravid Cohort, Denmark, 2007-2012. 
Pregnancies Cycles Modell Model2 FR (95% CI)a FR (95% CI)b 
Passive smoking in adulthood, 
hours/day 
0 1,272 7,385 1.00 (reference) 1.00 (reference) 
2: 1 354 2,324 0.90 (0.81-1.00) 0.92 (0.82, 1.03) 
1-2 275 1,798 0.90 (0.80-1 .02) 0.92 (0.81,1.04) 
2:3 79 526 0.89 (0.72-1.10) 0.92 (0.73,1.14) 
Passive smoking in adulthood and 
partner's current smoking status 
None, partner is not a regular 1,211 7,024 1.00 (reference) 1.00 (reference) 
smoker 
Some, partner is not a regular 253 1,693 0.88 (0.77-0.99) 0.90 (0.79,1.02) 
smoker 
None, partner is a regular smoker 61 361 0.98 (0.78-1.24) 1.00 (0.79, 1.26) 
Some, partner is a regular smoker 101 631 0.96 (0.80-1.16) 1.01 (0.83, 1.22) 
Passive smoking exposure by life stage 
No exposure 414 2,399 1.00 (reference) 1.00 (reference) 
Early life only 217 1,217 1.04 (0.89-1.22) 1.04 (0.89,1.21) 
Adolescence only 43 278 0.96 (0.71-1.30) 0.97 (0.72, 1.32) 
Recent adulthood only 73 444 0.91 (0.72-1.16) 0.92 (0. 72, 1.17) 
Early life and adolescence 598 3,491 1.00 (0.89-1.12) 1.01 (0.90,1.13) 
Early life and adulthood 20 192 0.68 (0.43-1.08) 0.69 (0.43, 1.10) 
Adolescence and adulthood 38 256 0.91 (0.65-1.29) 0.94 (0.66, 1.34) 
Exposed at all stages 223 1,432 0.93 (0.80-1.07) 0.97 (0.84,1.13) 
FR = fecundability ratio, CI =confidence interval. 
a Model 1 adjusted for cycle at risk. 
b Model2 additionally adjusted for age, education, and partner smoking (where 
applicable). 
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3. A PROSPECTIVE COHORT STUDY OF CAESAREAN SECTION AND 
SUBSEQUENT FECUNDABILITY 
3.1 ABSTRACT 
Background: Registry-based studies reported that women who delivered their frrst child 
by caesarean section (CS) were less likely to have another child than women who 
delivered their first child by spontaneous vaginal delivery. However, these studies lacked 
data on child-bearing intention and/or medical indication for CS. Methods: In a 
prospective cohort study of pregnancy planners in Denmark, 2007-2012, we evaluated 
the association between CS and fecundability among primiparous women delivering a 
singleton live birth. We used baseline and follow-up questionnaire data to collect data on 
fecundability, frrst occurrence of pregnancy, in 910 women. Data on prior delivery and 
obstetric complications were obtained via linkages to the Danish Medical Birth Registry 
and Danish National Registry of Patients. A proportional probabilities model estimated 
fecundability ratios (FR) and 95% confidence intervals (CI) adjusted for menstrual cycle 
at risk and potential confounders. Results: Fecundability was not reduced among women 
who had an emergency CS for an infant in cephalic presentation, the largest sub-group of 
CS births (FR=0.99, 95% CI: 0.80, 1.22 relative to spontaneous vaginal delivery). 
However, fecundability was reduced among women who had CS for an infant in breech 
presentation (FR=0.72, 95% CI: 0.53, 0.97), and among women who had an elective CS 
for an infant in cephalic presentation (FR=0.51, 95% CI: 0.25, 1.02). Conclusions: Our 
results do not support a deleterious effect of CS on future fecundability. The difference 
in association by fetal presentation at the time of CS suggests that underlying maternal 
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medical conditions or chance variation produced the inverse associations with 
fecundability. 
3.2 INTRODUCTION 
Deliveries by caesarean section (CS) constituted 20% oflive births in Denmark in 
2009 (1). CS is indicated for obstetric complications such as arrested labor and fetal 
distress (2, 3 ), although it also is performed in some cases because of maternal request ( 4) 
and repeat CS (3 , 5). 
A history of CS increases the risk of uterine rupture, placental abruption, placenta 
previa, and placenta accreta in subsequent pregnancies (6-11). Also, pelvic adhesions 
may develop from disordered healing of the peritoneum after CS (12-14) and may disrupt 
oocyte transport if they involve the ovaries or fallopian tubes (14). Adhesions can form in 
the absence of postoperative infection (12-14 ), and a study of adhesions noted in the 
operative summaries of285 consecutive women undergoing a repeat CS at a US Air 
Force base hospital detected adhesions in 53% (15). 
Several registry-based linkage studies have found fewer subsequent births among 
women with a history of primary CS relative to primary vaginal delivery ( 16-22). It is 
unclear whether the observed reduction in parity reflects a biological effect of 
complications from CS (23) or other phenomena, because these studies did not take into 
account factors such as the indication for CS, history of infertility, or intention for further 
childbearing (24). Two recent studies used data from birth and hospital registries to 
adjust for history of fertility treatments (25) and other medical diagnoses that could 
confound the relation of caesarean delivery with future parity (25, 26). Both studies 
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found a small reduction in subsequent parity associated with primary CS and concluded 
that the impact ofCS on future parity was either slightly inverse or non-existent. A 
registry-based study in Denmark found that primary CS was associated with an increased 
risk of ectopic pregnancy, miscarriage, and stillbirth, among women who had a second 
pregnancy (27). 
To our knowledge, no study has examined whether parents who try to have 
another child have a longer time-to-pregnancy if the first birth was delivered by CS. 
Among women with one previous singleton live birth who were attempting another 
pregnancy, we assessed the extent to which time-to-pregnancy and fecundability (the per-
cycle probability of pregnancy) differed between women delivering by caesarean section 
versus spontaneous vaginal delivery. We used data from a prospective cohort study of 
Danish pregnancy planners with data linkage to the Danish National Birth Registry and 
the National Registry of Patients to ascertain mode of delivery and maternal co-
morbidities. 
3.3METHODS 
Study Population 
The Snart-Gravid Study is a prospective cohort study of time-to-pregnancy that 
enrolled women planning a pregnancy in Denmark during 2007-2011. Study enrollment 
and primary data collection were conducted via the Internet. Snart-Gravid enrolled 5,046 
women age 18-40 years who were in a stable relationship with a male partner and were 
trying to conceive without receiving fertility treatments. All participants provided their 
informed consent, email address, and Civil Personal Registration number (CPR number), 
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a unique identification number assigned to all persons living in Denmark (28) that 
enables linkage with national health registries. 
Participants in the Snart-Gravid study who had one singleton live birth and no 
stillbirths before em:ollrrient were eligible for this analysis (1,406 participants). From this 
pool of eligible participants, we excluded 26 women whose previous birth was before 
1997, the year in which registry variable coding changed; 467 women who had been 
attempting pregnancy for >6 menstrual cycles at enrollment; and 2 women whose record 
had no information on the mode of delivery. Thus, 910 women constituted the fmal study 
population. 
Assessment of pregnancy and cycles at risk 
Participants responded to a baseline questionnaire at enrollment and follow-up 
questionnaires every two months for VP to 12 months. Participants contributed menstrual 
cycles at risk from the time they enrolled until they reported a pregnancy or were 
censored because they had completed 12 menstrual cycles of their pregnancy attempt 
without success, had started fertility treatments, or withdrew from the study. Total 
menstrual cycles at risk were calculated from the participant's reported number of months 
spent trying to conceive at the time of enrollment, the start of her last menstrual period 
(LMP date) before enrollment, the usual menstrual cycle length, and the date oflast 
menstrual period on each follow.,.up questionnaire (29), as follows: 
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Total menstrual cycles at risk 
Days trying to achieve pregnancy at enrollment 
cycle length 
+ (LMP date, last follow- up questionnaire- LMP date, baseline questionnaire) 
cycle length 
+1 
Assessment of exposure 
We linked records of births that occurred before study enrollment from the Danish 
Medical Birth Registry to Snart-Gravid questionnaire data by using the participant' s CPR 
number. The registry contains information on all births in Denmark reported by the 
attending midwife , and standardized information on medical care during labor and 
delivery, birth outcome, gestational age, birth weight, and obstetric complications (30, 
31). Medical diagnoses are recorded according to the Danish International Classification 
of Diseases, Tenth Revision (ICD-10). Using the ICD-10 code for type of delivery, we 
classified the birth as spontaneous vaginal delivery, instrumental vaginal delivery, or 
caesarean section (CS), and classified caesarean section as either elective or emergency 
(Table 9). 
Assessment of covariates 
We used a literature review and causal graphs to identify maternal co-morbidities 
and obstetric complications that were potential confounders (Table 9). These data were 
collected via linkage to the Danish National Patient Registry, which contains up to 20 
medical diagnoses for all hospitalizations since 1977 and for all visits to emergency 
rooms and outpatient clinics since 1995. We retrieved ICD-10 codes corresponding to 
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obstetric diagnoses, recorded at discharge dates ranging from 280 days before to 62 days 
after the delivery date; uterine leiomyoma (UL), recorded up to 62 days after the delivery 
date; and Mullerian anomalies, recorded at any time. 
The birth registry also recorded selected complications of pregnancy and 
childbirth with ICD-1 0 codes or indicator variables. Birth weight in grams was used to 
define macrosomia (>4,000 g) and low birth weight (<2,500 g) . Preterm and post-term 
deliveries were defined as gestational age <259 days and 2:294 days, respectively. Fetal 
presentation was recorded as one of 16 codes (Table 1 0). 
Selected diagnoses from the hospital and birth registries have been validated with 
medical chart review. The hospital registry recorded preeclampsia and gestational 
hypertension with specificity >99% and respective sensitivity, 69% and 10% (32). A 
validation study from the 1980s found the hospital registry had higher sensitivity and 
similar negative predictive value (NPV), compared with the birth registry, for placenta 
previa (sensitivity: 68% vs. 53%, NPV: 99%), placental abruption (sensitivity: 70% vs. 
66%, NPV: 97% vs. 96%), and polyhydramnios (sensitivity: 82% vs. 71%, NPV: 100%) 
(29). Records of uterine rupture in the birth registry had sensitivity=84% and 
specificity=99% compared with the medical record (33). Gestational age had low 
agreement with medical record data (46%) in the 1980s--before the extensive use of 
ultrasound to estimate gestational age--with systematic error that resulted in under-
estimating the prevalence of preterm birth by one-third (30). 
The Snart-Gravid baseline questionnaire elicited information on weight and 
height, reproductive and medical histories, and lifestyle habits such as frequency of 
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intercourse, smoking, and physical activity. Self-reported weight and height had excellent 
agreement with measurements from the first prenatal visit recorded in the registry 
(r2:0.96) among the Snart-Gravid participants who conceived a pregnancy that resulted in 
a live birth (29). Reproductive history included number of pregnancies, outcome and 
date of outcome for each pregnancy, and history of infertility: "have you ever tried for 
one year or more to become pregnant without becoming pregnant during that time?'' 
Participants reported the occurrence and date of occurrence of any of the following 
diagnoses: hypertension (not pregnancy-induced), thyroid disorder, diabetes, ovarian 
cyst, uterine fibroids, pelvic inflammatory disease, chlamydia, gonorrhea, genital herpes, 
vaginitis, and other sexually-transmitted infection. We also used self-reported intensity 
of menstrual flow as a proxy variable for uterine fibroids, with heavy or very heavy flow 
considered indicative of possible subclinical fibroids (34). The questionnaire asked, 
"How would you classify the total amount of your menstrual flow?" Options for response 
were: "light: :S10 pads or tampons," "moderate: 11-20 pads or tampons," "heavy: 21-30 
pads or tampons," and "very heavy: >30 pads or tampons." 
Data analysis 
We compared the fecundability among primiparous women with one prior CS 
with that of women with one prior spontaneous vaginal delivery by estimating the median 
time-to-pregnancy in each group. We also estimated the fecundability ratio (FR) and 95% 
confidence interval (CI) by fitting a proportional probabilities model (35), which is a 
discrete analog of the Cox Proportional Hazards Model (36). The model includes a 
binary indicator variable for each cycle number at risk, in order to adjust for the later 
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cycles' lower b~seline fecundability, which decreases steadily by cycle as fecund couples 
drop out of the cohort because they succeed at getting pregnant (37). A FR < 1.0 
corresponds to a reduction in average fecundability (increase in time-to-pregnancy) 
among the exposed relative to the unexposed. To check the proportional probabilities 
assumption, we plotted the log of minus log survival functions in the CS and spontaneous 
vaginal delivery groups. Several sub-analyses were designed to address threats to 
validity. First, we hypothesized that birth spacing may be longer on average after 
delivery by CS, and that longer birth spacing may mediate an association between CS and 
reduced fecundability. Longer birth spacing may be more common after CS owing to a 
higher prevalence of infants with adverse conditions that indicated the CS as well as a 
longer maternal recovery time. To address mediation by longer birth spacing, we 
stratified the analysis by interval from the first birth to the pregnancy attempt under study 
and also adjusted for the interval in the regression model. Second, allowing women to 
enroll after they have been attempting pregnancy for up to six cycles introduces the 
possibility for selection bias and misclassification ofcovariates. Thus, we restricted the 
analysis to participants who enrolled after attempting pregnancy for two or fewer cycles. 
Third, to clarify the effect of CS on fecundity independent of the effect of prior 
pregnancy loss, we stratified by gravidity (1 vs. > 1 prior pregnancy). 
We found that the vast majority of infants in breech presentation were delivered 
by CS, as were all infants in shoulder presentation. We expected that, among women 
who had a CS, some obstetric complications and maternal characteristics would be 
associated with breech/shoulder relative to cephalic presentation and with elective CS 
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relative to emergency CS. To evaluate confounding and assess differences in the 
association of CS and fecundability by indication for CS, we further categorized CS 
according to whether it was elective or emergency and according to fetal presentation 
(breech/shoulder, cephalic). Indications other than breech presentation for emergency CS 
differ from indications for elective CS. These distinctions therefore reflect differences in 
the indications for CS, not in the procedure itself. . 
We adjusted all analyses for maternal age at fust birth in years (<25, 25-29, 30-
34, 2:35), gestational age of first birth (<37 weeks, 37-41 weeks, 2:42 weeks), and interval 
in years from first birth to pregnancy attempt under study (<1.5, 1.5-2.9, 3.0-4.9, 2:5.0) 
(the interval). We categorized the interval according to the shape of the relation between 
the continuous interval and fecundability displayed in a restricted cubic spline (3 8) 
(Figure 1). Most other factors identified as potential confounders, including many 
obstetric complications and maternal reproductive and medical factors, were not 
appreciable confounders in our data. Body mass index (BMI: <20, 20-24, 25-29, 2:30 
kg/m2) and fetopelvic disproportion were included in the final model for CS and for 
emergency CS with cephalic presentation. Smoking history (never smoker, ever smoker 
<5 pack-years, ever smoker 5-9 pack-years, ever smoker 2:10 pack-years) and 
predisposing factors for breech presentation (UL, Mullerian anomaly, oligohydramnios, 
polyhydramnios, placenta previa) were included in the final model for CS with breech 
presentation. Appendix 1 contains the variables that were considered as potential 
confounders. 
In additional analyses, we adjusted each category of exposure-CS with breech 
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presentation, emergency CS with cephalic presentation, and elective CS with cephalic 
presentation-for its respective, estimated propensity score (39, 40), with spontaneous 
vaginal delivery as the reference condition. Each propensity score was estimated with a 
logistic regression model that included the potential confounders that were associated 
with fecundability (Appendix 2) ( 41 ). Plots of the propensity score distribution stratified 
by exposure category identified the range of scores with mutual overlap. We matched 
unexposed to exposed women 1 : 1 with a greedy matching algorithm that used matching 
criteria of 10-8 to 10-1 (42) and estimated the association ofhaving that category ofCS 
with fecundability in the matched population. To present the results in a clinically 
meaningful way, we plotted the cumulative probability of pregnancy by cycle among 
women in the CS and spontaneous vaginal delivery groups, adjusted for confounders, and 
estimated the median time-to-pregnancy in cycles. We estimated the cumulative 
probability function with a discrete-time Cox Proportional Hazards Model (36, 43) and 
adjusted for confounding with stabilized inverse probability oftreatment weights (44). 
A multiple imputation procedure applied to all participants imputed the missing 
values for certain covariates reported on the baseline questionnaire, including physician-
diagnosed health conditions and lifestyle habits ( 45). Analyses that included covariates 
with missing values were conducted in five data sets with these values imputed. We used 
PROC MIANAL YZE in SAS version 9.3 (SAS Institute, Cary, North Carolina) to 
account for the use of five imputed data sets when estimating the FR and 95% CI. 
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3.4 RESULTS 
During 12 cycles offollow-up, 708 (77.8%) ofthe 910 participants conceived, 43 
(4.7%) completed the study without conceiving, 48 (5.3%) initiated fertility treatment 
before the end of the study, and 111 (12.2%) withdrew. Participants who withdrew 
(median follow-up= 3 months) were more likely to have had a prior CS (28.8% vs. 
19.5%) and a history of infertility (31.5% vs. 14.9%) than participants who remained in 
the study. Also, they were more likely to have had the previous birth when they were 
age<25 (33.3% vs. 21.3%) or 2:30 (33.3% vs. 29.3%) and were on average heavier (mean 
BMI=25.7 vs. 24.6) and had waited longer since the prior birth to attempt another 
pregnancy (mean interval=2.9 years vs. 2.5) than participants who remained in the study. 
The crude frequency of births by mode of delivery was: CS 188 (20.7%, Table 
11), spontaneous vaginal delivery 585 (64.3%), instrumental vaginal delivery 137 
(15.0%). First birth by CS was associated with reduced fecundability in a subsequent 
pregnancy relative to first birth by spontaneous vaginal delivery (crude FR=0.81, 95% 
CI: 0.68, 0.96; Table 12). Among women with a spontaneous vaginal delivery, the 
adjusted 25th percentile, median, and 75th percentile for time-to-pregnancy were 3, 6, and 
10 cycles, respectively (Figure 2). Among women with a CS, the adjusted 25th percentile 
and median time-to-pregnancy were 4 and 8 cycles, respectively; only 72% of this group 
became pregnant over follow-up, so the 75th percentile was not calculable. 
Compared with women who had a spontaneous vaginal delivery, women who had 
a CS for breech presentation were more likely to be age2:30 at the time of the first birth 
and enrollment; to have had preterm delivery and polyhydramnios at the first birth; they 
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also had higher pack-years of smoking and caffeine intake. Women who had an 
emergency CS with cephalic presentation were on average older at the time of first birth, 
had a longer interval, had a higher BMI, and were more likely to have numerous 
complications affecting their pregnancy, labor, and delivery. History of infertility was 
similar in the CS and spontaneous vaginal delivery groups (Table 11 ). 
All but one of the 62 breech births were delivered by CS. The break-down of the 
188 CS deliveries by elective status and fetal presentation was: 59.6% emergency with 
cephalic presentation, 15.4% emergency with breech presentation, 8.0% elective with 
cephalic presentation, and 17.0% elective with breech presentation (Table 11). 
CS was inversely associated with fecundability if the fetal presentation was 
breech or shoulder (adjusted FR=0.72, 95% CI: 0.53, 0.97, Table 12), but not if it was an 
emergency CS with cephalic presentation (adjusted FR=0.99, 95% CI: 0.80, 1.22). 
Among the 15 women with an elective CS with cephalic presentation, 7 became pregnant 
over follow-up, and the crude FR was 0.51 (95% CI: 0.25, 1.02). Instrumental vaginal 
delivery was not appreciably associated with fecundability relative to spontaneous 
vaginal delivery (crude FR=0.98, 95% CI: 0.82, 1.18). 
Among women who were matched on propensity score, the association between 
emergency CS with cephalic presentation and fecundability was similar to the 
multivariable-adjusted association (FR=1.05, 95% CI: 6.79, 1.41; Table 13). The FR for 
CS with breech presentation was 0.77 (95% CI: 0.52, 1.13), and the FR for elective CS 
with cephalic presentation was 0.67 (95% CI: 0.26, 1.73). The range of propensity scores 
in the exposed and unexposed had sufficient overlap to provide a match for 98% of 
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participants who had CS with breech presentation, 84% of participants who had 
emergency CS with cephalic presentation, and 93% of the women who had elective CS 
with cephalic presentation (Table 13; Figures 3-5). The propensity scores were within 
1 o-2 for all matched pairs in the analyses of CS with breech presentation and elective CS 
with cephalic presentation and for 97% of the matched pairs in the analysis of emergency 
CS with cephalic presentation. 
In stratified analyses, delivery by CS was inversely associated with fecundability 
among women age<30 (all CS FR=0.74, 95% CI: 0.60, 0.92; breech CS FR=0.58, 95% 
CI: 0.40, 0.86; Table 14) but not among women age 2:30 (all CS FR=1.09, 95% CI: 0.81, 
1.47; breech CS FR=l.05, 95% CI: 0.65, 1.70). When we restricted the analysis to 
women trying <3 cycles at enrollment, the results were essentially the same as the overall 
results. In all strata of interval since last birth and all strata of gravidity, the respective 
associations of all CS and breech CS with fecundability were inverse, and these stratum-
specific associations did not meaningfully differ from one another (Table 14). There 
were some differences in the association of cephalic presentation emergency CS with 
fecundability when stratified by interval since last birth and by gravidity, but these 
differences may have been due to chance variation between strata (stratified by interval 
since last birth: <1.5 years: cephalic presentation emergency CS FR=1.21, 95% CI: 0.75, 
1.93; 1.5-2.9 years FR=0.94, 95% CI: 0.71, 1.24; 2:3 years FR=1.04, 95% CI: 0.65, 1.68; 
stratified by gravidity: gravidity=!: FR=1.05, 95% C::I: 0.80, 1.39; gravidity> 1: FR=0.86, 
95% CI: 0.62, 1.19. 
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3.5 DISCUSSION 
Among Danish primiparous women planning a second pregnancy, delivery by CS 
was associated with reduced fecundability relative to spontaneous vaginal delivery. 
Emergency CS with cephalic presentation-the most common type of CS-was not 
associated with fecundability, but CS with breech presentation and elective CS with 
cephalic presentation were associated with reduced fecundability. This variation by 
reason for the CS implies that the observed associations between CS and fecundability 
are not related to the CS itself. Rather, the reduced fecundability associated with breech 
CS and elective CS with cephalic presentation, respectively, is more plausibly related to 
residual confounding by maternal medical conditions, or chance variation. 
Maternal factors that would predict singleton breech presentation include delivery 
of the infant before 37 weeks of gestation, polyhydramnios, oligohydramnios, fetal 
malformation, or uterine factors such as fibroids and MUllerian anomalies ( 46). We could 
not distinguish between the effect of factors leading to breech birth and the effect of the 
CS itself because all but one breech birth were delivered by CS. Conditions that distort 
the uterine cavity to influence breech presentation-e.g., Mullerian anomalies and 
submucosal fibroids ( 4 7)-may contribute to secondary infertility if left untreated. 
Mullerian anomalies were more common among women who had CS with breech 
presentation, but fibroids were not (Table 11 ). Adjusting for these variables with a 
multivariable regression model made very little difference in the inverse association 
between breech CS and fecundability (Table 12). The FR estimated from data matched on 
propensity score was closer to the null than the FR estimated from the regression model, 
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which is in accordance with Rosenbaum and Rubin's observation that matching based on 
a propensity score is more effective than a regression model at balancing a large set of 
confounding variables when there are many potential matches (39). We would expect 
some residual confounding away from the null due to misclassification that may have 
resulted from imperfect sensitivity of hospital registry data and the high prevalence of 
asymptomatic and subclinical Mullerian anomalies and fibroids ( 48). 
The small number of women who had an elective CS with cephalic presentation and 
the various obstetric complications that were more prevalent among this group hindered 
analytical adjustment for confounding by regression modeling and matching on 
propensity score. The FR from the analysis among women matched on propensity score 
was substantially closer to the null than the crude estimate (0.67 versus 0.51 ). Applying 
the method of matching on propensity score may be useful in a larger study of subsequent 
fecundability among women who had an elective CS versus induced labor to address 
obstetric complications. 
Previous studies have found a lower probability of a subsequent birth (17-22, 25, 
26) and an increased risk of ectopic pregnancy, miscarriage, and stillbirth (27), associated 
with CS for first birth. Researchers have proposed several reasons for the reduced parity 
in women who had a caesarean. Clinical decision-making may tip towards CS if the 
couple has a history of infertility (49, 50). Also, the underlying causes of the obstetric 
complications may persist and make conceiving additional children difficult or 
inadvisable. These mechanisms were probably not present in our population because 
history of infertility did not differ by mode of delivery, and this was a study of pregnancy 
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planners. In one study conducted in the US, mode of delivery was not associated with the 
proportion of primiparous women who wanted another child or the proportion planning a 
birth spacing of~3 years (51). 
Caesarean delivery for a first-born child was associated with a lower probability 
of having another child in recent population-based prospective cohort studies conducted 
in the United States (risk ratio for absence. of subsequent birth over an eight-year period: 
1.15, 95% CI: 1.11, 1.19) (26) and in the United Kingdom (UK) (hazard ratio of having a 
second child ranging from 0.81-0.96, depending on indication, for a 12-year period) (25). 
These studies adjusted for certain medical diagnoses that could confound the relation of 
caesarean delivery with future fertility (25, 26). Results from two retrospective cohort 
studies conducted in the UK in the 1990s suggest that it may take longer to conceive 
another pregnancy after caesarean compared with vaginal delivery (19, 20), but these 
results were not adjusted for confounders such as medical diagnoses or infertility before 
the first childbirth. Therefore, it is uncertain whether the caesarean procedure itself 
impairs the capacity to establish pregnancy or sustain it. 
Our study has several strengths. We had self-reported information on infertility 
and found that it was not associated with mode of delivery after adjusting for age. CS was 
more common in mothers with a history of infertility in the Danish National Birth Cohort 
(50) and other studies (16, 19, 49). The possibility for selection bias related to using a 
study of pregnancy planners was minimized because, in Denmark, a relatively high 
number of pregnancies are planned (52, 53), and data were restricted to women who had 
been trying ~6 cycles at emollment. When we estimated FRs using only the women who 
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were trying for 2 or fewer cycles at enrollment, they were closely similar to the overall 
results (Table 12). 
Our study also has several limitations to consider. While we elicited information 
on history of infertility and found little association with CS, it is likely there were 
additional couples who were sub-fecund but did not meet the defmition of infertility, e.g., 
if they achieved the previous pregnancy in 11 months. We have no reason to suspect that 
women who were sub-fecund were more likely to have had CS, but it is possible. The 
expected bias in our estimates would be away from the null if this mechanism was 
operating in our data. The potential for residual confounding by preterm delivery and 
other pregnancy complications is more likely because they are under-reported in the birth 
registry and hospital. If there are under-reported obstetric complications that reflect 
underlying sub-fecundity and increase the likelihood of CS, non-differential under-
ascertainment of these complications would bias the CS-fecundability association away 
from the null. It is also plausible that ascertainment of obstetric complications that reflect 
underlying sub-fecundity is better when the mother has a CS. If that differential 
misclassification of covariates was present in our study, the expected bias in the observed 
associations would be towards the null. 
In summary, our results do not support a deleterious effect of CS on fecundability. 
Among women planning to have a second child, the association between one prior 
emergency CS with cephalic presentation and fecundability was null after adjustment for 
predisposing factors for CS. There were inverse associations between other types of 
CS-breech CS and elective CS with cephalic presentation-and fecundability. The 
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difference in association by type of CS suggests that underlying maternal medical 
conditions or chance variation contributed to the inverse associations with fecundability. 
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Table 9. ICD-10 codes identified from the first childbirth to define outcomes and 
obstetric complications. 
Outcome 
Spontaneous vaginal 
delivery 
Instrumental vaginal 
delivery 
Caesarean section 
Polyhydramnios 
Oligohydramnios 
Placental insufficiency 
Placenta previa 
Placental abruption 
Danish ICD-10 code Detailed diagnosis 
0800 Spontaneous delivery, 
cephalic presentation 
0801 Spontaneous delivery, 
breech presentation 
0802 Spontaneous delivery, 
unspecifiedb 
0814 Vacuum assisted delivery 
0820 Elective CS 
0821 Emergency CS, 
unspecified 
0821A Emergency CS due to 
complication before labor 
0821B Emergency CS due to 
pregnancy complication 
during labor 
0821C Emergency CS due to 
childbirth complication 
during labor 
0409 
0410 
(binary variable) 
0442 
0443 Placenta previa with 
hemorrhage 
0449 Placenta previa, 
unspecified 
0452 
0459 Premature separation of 
the placenta, confirmed 
a Prevalence of diagnosis found in hospital registry and birth registry. 
bAll births in this category were in cephalic presentation. 
Table 9 continued on next page ... 
Prevalence a 
(%) 
64.3 
15.0 
20.7 
0.3 
1.2 
3.3 
0.3 
0.7 
Table 9, continued .. . 
Outcome 
Fetal distress 
Fetopelvic disproportion 
Preterm premature rupture 
of membranes 
60 
Danish ICD-10 code 
0680 
0681 
0682 
0683 
0688 
0689 
0654 
0656 
Detailed diagnosis 
Childbirth complicated 
by fetal asphyxia and 
cardiac arrhythmia 
Childbirth complicated 
by fetal asphyxia and 
meconium 
Childbirth complicated 
by fetal asphyxia, 
cardiac arrhythmia, and 
meconium 
Childbiiih complicated 
by fetal asphyxia and 
acidosis 
Childbirth complicated 
by other signs of 
asphyxia 
Childbirth complicated 
by asphyxia, unspecified 
Fetopelvic 
disproportion, 
unspecified 
childbirth complicated 
by perineum rigidum 
0420 Premature rupture of 
membranes, GA<37 
wks, with regular 
contractions 
0422 Premature rupture of 
membranes, GA<37 
wks, without regular 
contractions 
a Prevalence of diagnosis found in hospital registry and birth registry. 
Table 9 continued on next page .. . 
Prevalence 
%a 
25.4 
5.0 
2.2 
Table 9, continued ... 
Outcome 
Preeclampsia and pre-
existing hypertension 
complicating pregnancy 
Diabetes 
61 
Danish ICD-10 code Detailed diagnosis 
0100 Pre-existing hypertension 
complicating pregnancy 
0139 Pregnancy-induced 
hypertension without 
proteinuria 
0140 Mild or moderate 
preeclampsia 
0141 Severe preeclampsia 
0142 HELLPc syndrome 
0149 Preeclampsia, 
unspecified 
0240 Pregnancy complicated 
by pre-existing type 1 
diabetes 
0241 Pregnancy complicated 
by pre-existing type 2 
diabetes 
0242 Pregnancy complicated 
by pre-existing diabetes 
caused by malnutrition 
0243 Pregnancy complicated 
by pre-existing diabetes, 
unspecified 
0244 Pregnancy complicated 
by gestational diabetes 
0245 New-onset diabetes, 
manifest in pregnancy 
0249 Pregnancy complicated 
by diabetes, uns. 
a Prevalence of diagnosis found in hospital registry and birth registry. 
c HELLP, Hemolysis, elevated liver enzymes, and low platelet count 
Table 9 continued on next page .. . 
Prevalence a 
% 
8.5 
3.8 
Table 9, continued ... 
Outcome 
Other abnormal 
conditions of the fetus 
Uterine leiomyoma 
Maternal Mullerian 
anomaly 
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Danish ICD-1 0 code Detailed diagnosis 
0360 Pregnancy with rhesus 
isoimmunization 
0362 Hemolytic disease of the 
newborn, 
erythroblastosis fetalis 
0368 Pregnancy with other 
abnormal condition of 
the fetus 
0369 Pregnancy with 
abnormal condition of 
the fetus, unspecified 
D250 Submucous leiomyoma 
D251 Intramural leiomyoma 
D252 Subserosalleiomyoma 
D259 Leiomyoma of uterus, 
unspecified 
0341 Maternal care for tumor 
of corpus uteri 
0340 Maternal care for 
congenital malformation 
of uterus 
0340A Maternal care for 
bicornate uterus 
0345, 0345A, Maternal care for other 
0345B, 0345C, abnormalities of gravid 
0345D uterus 
Q513 Bicornate uterus 
Q514 Unicornate uterus 
Q518 Other congenital 
malformations of uterus 
and cervix 
Q519 Congenital 
malformation of uterus 
and cervix, uns. 
a Prevalence of diagnosis found in hospital registry and birth registry. 
Prevalence a 
% 
1.8 
3.5 
0.6 
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Table 10. Danish Medical Birth Registry codes for fetal presentation. 
Code Description 
1 Regular cephalic presentation 
2 Irregular cephalic presentation 
3 Deep transverse 
4 Forehead presentation 
5 Brow presentation 
6 Face presentation 
7 Frank Breech 
8 Breech-foot: Complete foot 
9 Breech-foot: Incomplete foot 
10 Foot presentation 
11 Other breech 
12 Transverse lie/oblique lie 
13 Unengaged fetal head 
14 Asynclitism 
15 Unspecified cephalic presentation 
16 Unspecified breech presentation 
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Table 11. Baseline characteristics according to mode of delivery and fetal presentation in 
910 women with one Erior live birth: Snart-Gravid Studr, Denmark, 2007-2012.a 
Vaginal delivery CS, CS, Cephalic 
Spontaneous Vacuum-
Breech 
Emergency 
assisted Elective 
Number of women, n 585 137 61 112 15 
Age at first birth ~30 years (%) 27 34 34 36 27 
Age at enrollment, years(%) 
18-24 8 3 2 8 0 
25-29 37 42 35 35 39 
30-34 42 41 47 44 49 
~35 13 15 16 13 13 
Time since last birth,b years 
(median) 2.2 2.1 2.0 3.7 2.0 
Attempt time at enrollment <3 58 54 50 57 44 
cycles(%) 
BMI, kg/m2 (mean) 24.5 24.1 24.6 26.2 25.3 
Vocational training(%) 
None, basic, or <3 years 41 34 33 42 40 
Obstetric complications 
Birth weight <2,500 g (%) 2 1 3 11 0 
Birthweight~4,000g(%) 13 13 12 27 16 
Prior miscarriage (%) 6 3 5 8 0 
Hypertensive disorderc (%) 7 11 7 15 8 
PPROMd (%) 2 1 6 3 0 
Preterme (%) 6 3 11 11 0 
Post-termr (%) 7 8 6 18 0 
Placenta previa(%) 0 0 0 0 2 
Placental abruption (%) 1 0 2 2 0 
Polyhdramnios (%) 0 0 2 2 0 
Oligohydramnios(%) 1 0 0 4 5 
a With the exception of age at first birth, statistics are standardized to the population distribution 
of age at first birth. 
b Interval from prior birth to start of the pregnancy attempt under study. 
c Includes preeclampsia, eclampsia, pre-existing hypertension, pregnancy-induced hypertension 
without proteinuria, pregnancy-induced proteinuria without hypertension. 
d PPROM, preterm premature rupture of membranes. · 
e <3 7 weeks gestation 
r~41 weeks gestation 
Table II continued on next page ... 
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Table 11, continued 
Vaginal delivery cs, CS, Cephalic 
Spontaneous Vacuum- Breech Emergency Elective 
assisted 
Labor and delivery 
complications 
Fetal distress(%) 17 57 3 46 13 
Fetopelvic disproportion(%) 3 2 1 19 16 
Fetal presentation(%) 
Vertex 98 84 0 19 40 
Cephalic, unspecified 2 13 0 13 0 
Cephalic Malpresentation 0 3 0 67 60 
Breech <1 0 100 0 0 
Induced/augmented labor (%) 16 10 1 31 0 
Caesarean section on maternal 
request(%) 0 0 1 4 32 
Reproductive and medical 
history 
Infertilit/ (%) 17 16 16 18 16 
Fibroids (%) 4 6 0 2 5 
Mullerian anomaly (%) 0 0 3 0 5 
Thyroid disorders (%) 4 5 5 0 0 
Diabetesg (%) 4 4 1 4 13 
Last contraceptive (%) 
Hormonal methodsh 51 46 54 55 37 
Barrier methods 39 44 40 34 54 
Withdrawal, charting, 
other 11 10 6 11 11 
Regular cycles(%) 78 79 79 88 63 
Cycle length, days (mean) 30.1 29.8 29.3 29.1 29.5 
Very heavy menstrual flow 
(%) 3 1 5 2 8 
Lifestyle habits 
Frequency of intercourse: 
~2 times/week (%) 57 56 50 55 57 
Timing for fertile window (%) 50 58 59 58 39 
Pack-years of smoking (mean) 2.6 2.6 2.9 2.5 0.8 
Caffeine, mg/day (mean) 160 153 171 135 160 
>7 Alcoholic drinks/wk (%) 7 7 7 7 0 
1 Participant reported an episode before the pregnancy attempt under study when she attempted 
pregnancy for> 12 months without success. 
g Includes gestational and pre-existing diabetes. 
b Includes oral contraceptive pills, injectable contraceptives, and patch contraceptives 
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Table 12. Caesarean section and fecundability in 773 women with one prior live birth: 
Snart-Gravid Study, Denmark, 2007-2012. 
Spontaneous vaginal 
delivery 
All CSc 
CS, breech presentationd 
Emergency CS, 
cephalic presentatione 
Elective CS, 
Pregnancies 
463 
134 
40 
87 
cephalic presentation 7 
•Model 1 is adjusted for cycle number at risk. 
b Reference category. 
Cycles 
2,013 
745 
259 
419 
67 
Model 1 
FR (95% CI)" 
l.OOb 
0.81 (0.68, 0.96) 
0.70 (0.53, 0.95) 
0.92 (0.75, 1.12) 
0.51 (0.25, 1.02 ) 
Model2 
FR (95% CI) 
l.OOb 
0.85 (0.71, 1.01) 
0.72 (0.53, 0.97) 
0.99 (0.80, 1.22) 
c Model 2 is adjusted for age at first birth, gestational age of first birth, interval from first birth to 
start of current pregnancy attempt, body mass index, and fetopelvic disproportion. 
d Model 2 is adjusted for age at first birth, gestational age of first birth, interval from first birth to 
start of current pregnancy attempt, fibroids diagnosis from self-report or hospital registry, 
Mullerian anomaly diagnosis from hospital registry, intensity of menstrual flow at baseline, pack-
years of smoking at baseline, and risk factors for breech presentation (oligohydramnios, 
polyhdramnios, and placenta previa). 
e Model 2 is adjusted for age at first birth, gestational age of first, interval from first birth to start 
of current pregnancy attempt, fetopelvic disproportion at first birth, and body mass index at time 
of study enrollment. 
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Table 13. Categories of caesarean section in relation to fecundability among women 
matched on propensity score for caesarean section: Snart-Gravid Study, Denmark, 2007-
2012 
Number 
of women Pregnancies Cycles FR (95% CI)a 
Spontaneous vaginal delivery 60 47 226 l.OOb 
CS, breech presentation 60 40 256 0. 77 (0.52, 1.13) 
Spontaneous vaginal delivery 94 70 346 l.OOb 
Emergency CS, 
cephalic presentation 94 73 349 1.05 (0.79, 1.41) 
Spontaneous vaginal delivery 14 8 52 l.OOb 
Elective CS, 
ceEhalic Eresentation 14 6 65 0.67 ~0.26, 1.73) 
a FR and 95% CI were adjusted for cycle number at risk. 
b Reference category. 
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Table 14. Stratified analyses of caesarean section and fecundability in 758 women with 
one Erior live birth: Snart-Gravid Studl:, Denmark, 2007-2012. 
Spontaneous CS, breech or Emergency CS, 
vaginal shoulder cephalic 
delive!l All CSa 12resentationb 12resentationc 
Age at first birth: 
<30 years 
Pregnancies 348 86 25 58 
Cycles 1,417 528 186 282 
FR (95% CI) 1.00d 0.74 (0.60, 0.92) 0.58 (0.40, 0.86) 0.96 (0.74, 1.24) 
?:30 years 
Pregnancies 115 48 15 29 
Cycles 596 217 73 137 
FR (95% CI) 1.00d 1.09 (0.81, 1.47) 1.05 (0.65, 1.70) 1.03 (0.70, 1.49) 
Gravidity at baseline: 
Primigravid 
Pregnancies 285 86 31 53 
Cycles 1,253 465 190 244 
FR (95% Cl) 1.00d 0.89 (0.72, 1.12) 0.81 (0.58, 1.15) 1.05 (0.80, 1.39) 
Multigravid 
Pregnancies 178 48 9 34 
Cycles 760 280 69 175 
FR (95% CI) l.OOd 0. 77 (0.57, 1.03) 0.57 (0.30, 1.06) 0.86 (0.62, 1.19) 
a Model is adjusted for age at first birth, gestational age of first birth, interval from first birth to 
start of current pregnancy attempt, body mass index, and fetopelvic disproportion. 
b Model is adjusted for age at first birth, gestational age of first birth, interval from first birth to 
start of current pregnancy attempt, fibroids diagnosis from self-report or hospital registry, 
Mullerian anomaly diagnosis from hospital registry, intensity of menstrual flow at baseline, pack-
years of smoking at baseline, and risk factors for breech presentation (oligohydramnios, 
polyhdramnios, and placenta previa). 
c Model is adjusted for age at first birth, gestational age of first, interval from first birth to start of 
current pregnancy attempt, fetopelvic disproportion at first birth, and body mass index at time of 
study enrollment. 
d Reference category. 
Table 14 continued on next page .. . 
Table 14, continued 
Spontaneous 
vaginal 
delivery 
Interval from first birth to start 
of current pregnancy attempt: 
<1.5y 
Pregnancies 115 
Cycles 543 
FR (95% CI) l.OOd 
1.5-2.9 y 
Pregnancies 240 
Cycles 949 
FR (95% CI) l.OOd 
2:3 y 
Pregnancies 108 
Cycles 521 
FR (95% CI) 1.00d 
<3 Cycles trying at enrollment 
Pregnancies 34 7 
Cycles 1,456 
FR (95% CI) 1.00d 
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All cs• 
32 
198 
0.73 (0.50, 1.07) 
71 
346 
0.89 (0.70, 1.13) 
31 
201 
0.83 (0.57, 1.20) 
97 
507 
0.86 (0.71, 1.05) 
CS, breech or 
shoulder 
presentationb 
10 
91 
0.49 (0.27, 0.90) 
21 
101 
0.94 (0. 75, 1.17) 
9 
67 
0.74 (0.40, 1.37) 
29 
173 
0.75 (0.54, 1.04) 
Emergency CS, 
cephalic 
presentation c 
22 
96 
1.21 (0.75, 1.93) 
48 
229 
0.94 (0.71, 1.25) 
17 
94 
1.04 (0.65, 1.68) 
64 
297 
1.00 (0.79, 1.25) 
a Model is adjusted for age at first birth, gestational age of first birth, interval from first birth to 
start of current pregnancy attempt, body mass index, and fetopelvic disproportion. 
b Model is adjusted for age at first birth, gestational age of first birth, interval from first birth to 
start of current pregnancy attempt, fibroids diagnosis from self-report or hospital registry, 
Mullerian anomaly diagnosis from hospital registry, intensity of menstrual flow at baseline, pack-
years of smoking at baseline, and risk factors for breech presentation (oligohydramnios, 
polyhdramnios, and placenta previa). 
c Model is adjusted for age at first birth, gestational age of first, interval from first birth to start of 
current pregnancy attempt, fetopelvic disproportion at first birth, and body mass index at time of 
study enrollment. 
d Reference category. 
70 
Figure 1 
Age-adjusted fecundability ratio for interval from last birth to pregnancy attempt under 
study, relative to median value, 2 years. Four knots placed at 0.97, 1.7, 2.4, and 5.1 years. 
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Figure 2 
Cumulative percent of women pregnant by mode of delivery, 
adjusted for maternal age at first birth, gestational age at first birth, 
fetopelvic disproportion at first birth, interval from first birth, and current maternal BMI. 
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Figure 3 
Comparison of propensity score distribution: 
584 women with spontaneous vaginal delivery (top) and 112 women with emergency 
caesarean section for an infant in ce halic resentation bottom . 
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Figure 4 
Comparison of propensity score distribution: 
585 women with spontaneous vaginal delivery (top) and 61 women with caesarean 
section for an infant in breech presentation (bottom). 
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Figure 5 
Comparison of distribution of propensity score: 584 women with spontaneous vaginal 
delivery (top) versus 15 women with elective caesarean section 
for an infant in cephalic presentation (bottom). 
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4. ERROR IN MATERNAL RECALL OF TIME-TO-PREGNANCY 
4.1 ABSTRACT 
Background: Epidemiologic studies of fecundability often rely on retrospectively-
measured time-to-pregnancy (TTP), which introduces potential for recall error. There 
has been little investigation into how recall error affects the bias and precision of the 
effect estimate in studies of fecundability determinants. Methods: We quantified the 
measurement error of TTP recalled in the first trimester relative to prospectively-
measured TTP, using data from the Snart-Gravid Study in Denmark, 2007-2012. The 
analysis included 425 women with <1 month of attempt time at study entry who became 
pregnant within 12 months of follow-up and reported their TTP in months. We defined 
recall error as retrospectively-measured TTP minus prospectively-measured TTP and 
used linear regression models to evaluate associations with prospectively-measured TTP 
and several maternal characteristics. We conducted a quantitative bias analysis that 
demonstrates the change in the association of last contraceptive method and fecundability 
after correcting for recall error in retrospectively-measured TTP. Results: Recall error 
ranged from -9 to 3 months with a mean of -0.11 months (95% CI: -0.25, 0.04). The 
prevalence of reports with recall error> 1 month was 11% (95% CI: 8, 14). Incorporating 
the measure of recall error into the quantitative bias analysis resulted in a similar point 
estimate and a wider confidence interval, compared with the results from the 
retrospective TTP data. Conclusions: Recall error was small on average among 
pregnancy planners who enrolled in a prospective cohort study in the first month of their 
pregnancy attempt and recalled their TTP in the first trimester. Using retrospectively-
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measured TTP to estimate the association of recent oral contraceptives use on 
fecundability resulted in no meaningful bias, and a quantitative bias analysis conveyed 
the additional uncertainty in the result that was due to measurement error. 
4.2 INTRODUCTION 
Most studies investigating determinants of fecundability use retrospectively-
collected data from pregnant women who enroll at a prenatal appointment and recall their 
time-to-pregnancy (TTP) if the pregnancy was planned and conceived without fertility 
treatments (1). Examples include the Danish National Birth Cohort (2) and Norwegian 
Mother and Child Cohort Study (3). 
Systematic error in retrospectively-measured TTP can introduce bias in the 
fecundability ratio (FR), the ratio of the cycle-specific pregnancy probability in the 
exposed relative to the unexposed population (4). Differential misclassification of 
retrospectively-measured TTP with respect to exposure could bias an observed 
association away from the null, e.g., if older women tend to over-estimate their TTP and 
younger women tend to under-estimate their TTP ( 4). 
Baird et al. (1) compared the distribution of retrospectively-measured TTP from 
656 pregnant women who conceived in :S12 months with the distribution of 
prospectively-measured TTP values from a study of 611 women who attempted 
pregnancy following intrauterine device removal (5) and found the cumulative percent 
pregnant in cycles 1-6 was 1%-6% higher per cycle in the retrospectively-measured TTP 
measure (1, 5). This suggests the retrospectively-measured TTP was under-estimated on 
average. Another study compared retrospectively-measured TTP reported by 100 women 
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3-20 months after they participated in a prospective TTP study (6), and found the mean 
difference in retrospectively-measured minus prospectively-measured TTP was -0.6 
months (95% confidence interval: -1.7, 0.5). However, the prospectively-measured TTP 
included a retrospective component for an undisclosed proportion of participants who had 
been trying to conceive before enrollment (6). To our knowledge, no study has assessed 
systematic error in TTP reported in pregnancy relative to an entirely prospective measure 
of TTP from the same population. 
A validation study of retrospectively-reported TTP after 10 years found that 
longer TTP and having had a previous pregnancy were associated with under-estimated 
retrospectively-measured TTP (7). Longer TTP was also associated with lower reliability 
of self-reported TTP in a study that assessed the agreement of retrospective reports of 
TTP collected after one year and again 10-16 years later (8). If the likelihood of under-
estimating retrospectively-measured TTP increases in proportion to the value of 
prospectively-measured TTP, the FR may be biased towards the null. 
In the present study, we quantified the error ofTTP recalled in the first trimester, 
relative to prospectively-measured TTP using data provided by Danish women who had 
participated in a prospective cohort study of TTP and conceived within :S12 menstrual 
cycles. We also assessed systematic error in retrospectively-measured TTP stratified by 
prospectively-measured TTP and several covariates (maternal age, gravidity, menstrual 
cycle regularity, and last contraceptive method). We conducted a quantitative bias 
analysis to demonstrate how to use these estimates of the recall error to correct 
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retrospectively-measured TTP and obtain an effect estimate that was not biased by recall 
error. 
4.3 METHODS 
Study Population 
The Snart-Gravid Study, conducted in Denmark from 2007-2012, emolled women 
who were age 18-40 years, attempting pregnancy with a male partner, not using fertility 
treatments, and willing to provide their email address and identification number for the 
Central Person Registry (9). Participants provided their eligibility, informed consent, 
exposure information, and pregnancy status via Internet-based questionnaires. The 
baseline questionnaire elicited data on the current length of the pregnancy attempt in 
months, date of last menstrual period (LMP date), menstrual cycle length and regularity, 
body size, reproductive and medical histories, and lifestyle habits such as intercourse 
frequency, smoking history, and physical activity. Every two months, participants 
received an email invitation to complete a follow-up questionnaire, and non-respondents 
received up to two reminders. Active follow-up ended when participants reported they 
were pregnant, using fertility treatments, or no longer attempting pregnancy, or after they 
completed six follow-up questionnaires, whichever came first. 
Of 5,046 women emolled in Snart-Gravid, we excluded 4,293 women who 
emolled after the first month of attempting pregnancy and another 251 women who did 
not report that they were pregnant on a follow-up questionnaire. As a result of the 
original study design, all of the women who emolled in the fust month of their pregnancy 
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attempt and achieved pregnancy during active follow-up had TTP :S13 months. 
Additional criteria for exclusion were: missing retrospectively-measured TTP (N=31 ), 
missing LMP date at baseline (N=8), missing LMP date in early pregnancy (N=l), 
reporting an LMP date in early pregnancy that was too recent to be plausible (:S9 days; 
N=3), and missing one of the exposure variables, cycle regularity, gravidity, body mass 
index (BMI), or vigorous physical activity (N=4). Thus, 455 women were included in the 
analysis. 
Data Collection 
The baseline questionnaire collected information on age, gravidity, the first day of 
the last menstrual period (LMP date), cycle length and regularity, and last method of 
contraception. The follow-up questionnaires collected information every two months on 
cycle length, LMP date, and pregnancy status. Prospectively-measured TTP was defmed 
as the interval in months from the beginning of the first menstrual cycle when the 
participant and her partner tried to become pregnant to the middle of the menstrual cycle 
when they conceived a recognized pregnancy. Thus, we calculated prospectively-
measured TTP in days, divided by 30.25 to convert days into the approximate number of 
months, and rounded to the nearest integer: 
Prospectively-measured TTP = [(LMP date on follow-up questionnaire when they 
reported a pregnancy+ (1 /2)*(length of average menstrual cycle in days))- LMP date on 
baseline questionnaire] I 30.25 
Retrospectively-measured TTP was ascertained on the early pregnancy 
questionnaire with the question, "How many months did it take you to get pregnant?" 
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Retrospectively-measured TTP in months was reported as an integer 2:0; therefore, it was 
a rounded value. We interpreted a report of TTP = 0 as getting pregnant in the first month 
oftrying (TTP = 1 month) and grouped these with reports ofTTP=1 in the analysis, 
consistent with previous retrospective TTP studies (10). 
Cycle regularity was defined as either regular or irregular according to the 
response to the question, "Within the past couple of years, has your menstrual period 
been regular during those time periods [if applicable] when you were not using hormonal 
contraceptives?" (yes or no). Participants were defined as gravid ifthey responded yes to 
the question, "have you ever been pregnant?" Last contraceptive method was reported 
from a multiple-choice question and categorized for analytic purposes as either oral 
contraceptives (OCs), barrier methods (condom, foam, gel, cream, sponge, suppository, 
or intrauterine device), or other method (hormone injection, patch, or ring; calendar, 
temperature, withdrawal, or unspecified). 
Statistical Analysis 
We estimated the probability of under-estimating and over-estimating TTP, 
respectively, using prospectively-measured TTP as the benchmark. Recall error was also 
quantified as an absolute value (error =retrospectively-measured TTP- prospective 
TTP) and as a percent of prospective TTP (100% *(error I prospective TTP)). We 
assessed the respective associations of these two specifications of recall error with age 
(age2:30 vs. age<30), gravidity (gravid vs. nulligravid), prospectively-measured TTP (>2 
vs. :S2), cycle regularity (irregular vs. regular), and last contraceptive method (oral 
contraceptives vs. barrier methods). We estimated recall error differences (difference) 
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from linear regression models. 
Our estimate of recall error can inform bias analyses in studies of fecundability 
that measure TTP retrospectively (11). We demonstrated how measures ofrecall error 
can be used to reconstruct probable, prospectively-measured TTP values from 
retrospectively-measured TTP and conduct a quantitative bias analysis of the association 
of an exposure and fecundability to correct for mismeasured TTP. The quantitative bias 
analysis examined an association previously studied in the full Snart-Gravid cohort (12), 
comparing fecundability in women who last used oral contraceptives relative to women 
who last used barrier methods by calculating the fecundability difference (FD) by month 
at risk. First, we calculated FD by month by using the prospectively-measured TTP 
values, and then by using the retrospective TTP values (conventional analysis). We used 
months at risk 1-6 because in our small study population, some of the later months had no 
pregnancies in one ofthe exposure categories. From the distribution of prospectively-
measured TTP conditional on retrospectively-measured TTP, each retrospective TTP 
value had a vector of probabilities for prospectively-measured TTP values, i.e., a 
tabulated distribution of probabilities. These probabilities can be thought of as a positive 
predictive value and a series of negative predictive values. Then to demonstrate the utility 
of the method, we proceeded as if we had no access to the retrospectively-measured TTP 
data and used these predictive probabilities to probabilistically assign each person in the 
dataset a prospective TTP given their observed retrospectively-measured TTP. We 
repeated this process 100,000 times (simulation analysis) each time calculating the 
month-specific FD. This created a distribution of corrected estimates that account only 
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for the uncertainty in the systematic error caused by error in recalling TTP. Then, we 
incorporated the random error from the conventional analysis into each month-specific 
FD in each simulated data set. We subtracted the product of the standard error from the 
conventional analysis and a number drawn randomly from a standard normal distribution 
(13) to create a distribution that accounted for both the systematic and random error. We 
summarized these distributions using the median as the point estimate and the 2.51hand 
97.51h percentile values to create 95% uncertainty intervals for the month-specific FDs 
(13). All analyses were conducted in SAS version 9.3 (SAS Institute, Cary, North 
Carolina). 
4.4 RESULTS 
The majority of women (N=425, 93% of the study population) retrospectively-
reported their TTP in the first trimester. The 30 women who responded in the second 
trimester (median gestational age= 14 completed weeks, interquartile range= 13 -16), had 
on average a longer prospectively-measured TTP (TTP>2 months: 57% vs. 48%) and a 
greater likelihood of any recall error (60% versus 48%), compared with women who 
responded in the first trimester. Because they were different based on these statistics and 
few in number, women who responded in the second trimester were not analyzed further. 
The median gestational age at which the 425 participants reported their TTP in the 
first trimester was 8 weeks (interquartile range: 6- 10). For the most part, women were 
under 30 years of age (62%, Table 15), were lean (BMI<25: 74%), had regular menstrual 
cycles (80%), used OCs as their last method of contraception (58%), were in their frrst 
83 
pregnancy (53%), had no prior live births (61 %) and did not smoke (88%). 
Four women with prospectively-measured TTP2:8 months reported TTP=1 month. 
Based on their responses to questionnaires, we decided their prospectively-measured TTP 
values were probably impacted by a long period of non-response (e.g., an intervening 
miscarriage) and did not analyze them further. 
Fifty-three percent of retrospective TTP reports agreed with the prospective 
measure, 27% were under-estimated, and 20% were over-estimated (Table 17). Recall 
error 2:2 months occurred in 12% of reports. Recall error in absolute months ranged from 
-6 to 3 with a median of 0 and a mean of -0.11 months (95% CI: -0.25, 0.04). Recall error 
as a percent of prospectively-measured TTP had a mean of 4% (95% CI: 0, 8%). There 
was more under-estimation of retrospectively-measured TTP associated with 
prospectively-measured TTP >2 relative to prospectively-measured TTP :S2, expressed as 
difference in absolute recall error ( -0.42 months, 95% CI: -0. 73, -0.11 ), and as difference 
in percent recall error (-17%, 95% CI: -25%, -8%). Women with irregular cycles tended 
to have more negative recall error than women with regular cycles ( difference=-0.25 
months, 95% CI: -0.55, 0.05; difference=-13%, 95% CI: -21%, -5%). There was very 
little difference in recall error by age 2:30 (relative to age<30: difference=-0.003 months, 
95% CI: -0.36, 0.35; difference=-2%, 95% CI: -8%, 11 %) or gravidity (relative to 
nulligravid women, difference =-0.02 months, 95% CI: -0.35, 0.13; difference=O%, 95% 
CI: -9%, 9%). Compared with women who used barrier methods as their last method of 
contraception, recall error was not substantially different among women who last used 
OCs (difference=-0.04 months, 95% CI: -0.36, 0.28; difference=4%, 95% CI: -5%, 13%), 
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while women who last used other contraceptive methods were more likely to 
underestimate TTP (difference=-0.66 months, 95% CL -1.23, -0.07; difference=-22%, 
95% CI: -39%, -6%). 
Because TTP tended to be under-estimated for prospectively-measured TTP 
values>2, the cumulative percent of pregnancy was slightly higher in months 3, 4, and 5 
when it was calculated from retrospectively-measured TTP compared with prospectively-
measured TTP (Figure 6). 
Sensitivity analyses 
The longest interval between completing follow-up questionnaires was <3 
menstrual cycles for 95% of women responding in the first trimester and <2 menstrual 
cycles for 41%. We conducted two sensitivity analyses with respective restrictions to 
women who responded in <3 and <2 menstrual cycles. In each ofthese sensitivity 
analyses, results were similar to the results from the primary analysis (Tables 18 and 19; 
Figures 7 and 8). 
Bias Analysis 
The bias analysis used data from 386 women whose last method of contraception 
was OCs (N=247) or barrier methods (N=139). We reconstructed prospectively-
measured TTP values from retrospectively-measured TTP values using the conditional 
probability distribution (probabilities of prospectively-measured TTP within values of 
retrospectively-measured TTP) among these 386 women since a conditional probability 
distribution that included women who had last used other methods of contraception 
would reflect their tendency toward greater under-estimation. 
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Using prospectively-measured TTP, the use ofOCs as the last contraceptive 
method was associated with a lower fecundability in the first month of trying (FD = -
13%, 95% CI: -23%, -4%; Table 20). In subsequent months, the FD estimates were near 
zero for the most part and imprecise due to fewer pregnancies and women at risk. 
Repeating this analysis using retrospectively-measured TTP yielded an FD that was 
somewhat farther from the null in month 1 (FD=-20%, 95% CI: -29%, -10%). 
Using the corrected TTP values, the median FD was similar to what it was in the 
analysis using prospectively-measured TTP, indicating that on average, the 100,000 
simulations approximated the analysis of prospectively-measured TTP. However, there 
was substantial uncertainty caused by the bias, as reflected in the interval that accounted 
only for systematic error. The simulation intervals incorporating total study error 
(systematic and random) were substantially wider than the conventional results (cycle 1 
FD = -15%, 95% simulation interval: -27%, -3%). 
4.5 DISCUSSION 
In this study of pregnancy planners who had participated in a prospective study of 
TTP and who were asked to recall their TTP in early pregnancy, recall error of TTP was 
on average small. Under-estimation ofTTP was greater with prospectively-measured 
TTP>i relative to prospectively-measured TTP:S2. There was also more under-
estimation on average associated with irregular cycles relative to regular cycles, and use 
of fertility-awareness or withdrawal as the last contraceptive method relative to use of 
barrier methods. Average recall error was similar when we compared women age<30 
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with women age ~30, nulligravid women with gravid women, and women who used OCs 
as the last contraceptive method relative to barrier methods. 
This study was the first to compare TTP recalled in pregnancy to prospectively-
measured TTP from the same participants. Baird et al. compared values of TTP :S 6 
cycles recalled during the first six months of pregnancy with data from a prospective TTP 
study and found similar distributions (1 ). Zielhuis et al. evaluated error in TTP recalled 
after 3-20 months among 100 women who had participated in a prospective study of early 
pregnancy loss (6) and found there was very little error on average (difference in 
retrospectively-measured and prospectively-measured TTP: mean =-0.6 months, 95% CI: 
-1.7, 0.5). In that study, the gold standard of prospectively-measured TTP included data 
from participants who had already been attempting pregnancy for several months when 
they enrolled. The study did not report the number of participants who were already 
trying at enrollment or the range of months trying at enrollment (6). This study also 
differed from ours in that it included women with TTP > 12 months. 
We assessed the impact of this small amount of recall error on the FD and 
uncertainty interval by conducting analyses of the association of last contraceptive 
method and fecundability in the prospectively-measured TTP data, retrospectively-
measured TTP data, and reconstructed prospectively-measured TTP data in 100,000 
simulated data sets. Compared with the FD from the prospectively-measured TTP data, 
the FD from the retrospectively-measured TTP was essentially unbiased, but the 95% 
confidence interval did not convey the additional uncertainty from an analysis of 
retrospectively-measured TTP subject to recall error. Incorporating random and 
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systematic error into the FDs resulted in an uncertainty interval that was 20% wider than 
the 95% confidence interval from the retrospectively-measured TTP analysis (i.e., 24 
versus 20). This illustrates that the frequentist confidence interval gives an over-
confident interpretation about the precision of the results from an epidemiologic study 
(14). 
The quantitative bias analysis builds on the method presented by Baird et al. 1991 
(4), which illustrated that misclassification ofTTP decreases study precision. That 
method may inform study design considerations such as selecting an appropriate sample 
size for study of an exposure with fecundability in the presence of misclassified TTP. In 
contrast, our method corrects for the bias in the data analysis and the accompanying 
uncertainty it creates once exposure and outcome have been collected. 
Our finding that longer prospectively-measured TTP was associated with greater 
under-estimation of TTP is in agreement with the results from a previous validation study 
of TTP recalled after 1 0 years (7) and two reliability studies of TTP recalled after 1-4 
years (4) and 11-16 years (8). Cognitive psychology studies have reported that recalling 
the timing of past events is subject to a telescoping effect, in which the duration since a 
past event tends to be under-estimated (15). Another reason for this result is intuitive: 
larger values of TTP have more room for error. 
Women with irregular cycles may give a somewhat less accurate report of TTP 
when the unit of time is months, not cycles. In planning their pregnancy, they naturally 
would become accustomed to thinking of cycles as the unit of time, and their menstrual 
cycles may tend to last >30 days. These features could make it harder for them to 
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understand what the question is asking and harder to recall their TTP in months. 
Questionnaire design can enhance reporting accuracy by eliciting retrospectively-
measured TTP in cycles, instead of or in addition to TTP in months. 
By design, the range ofTTPs in our analysis was narrow, which limited our 
ability to assess digit preference. Other authors assessed digit preference in fecundability 
studies (16) and found preferences for TTP values of 6 and 12. A validation study of 
recall error after 10-15 years suggests a digit preference for TTP = 1 cycle (7). 
Retrospectively-measured TTP differed from prospectively-measured TTP by 2:1 
month 48% of responses, and by ~2 months in only 12%. It may be that most women 
failed to recall the precise value of TTP, although they were able to recall its approximate 
value. There are alternative explanations for the preponderance of responses with a small 
amount of discrepancy between prospectively-measured and retrospectively-measured 
TTP. The discrepancy may reflect the margin of error for reporting as an integer the 
inherently continuous measure of TTP in months. Some women may have 
misunderstood the question and reported how many months they tried before the month 
when they got pregnant. Some women may have reported TTP in cycles instead of 
months. Limitations in data collection by questionnaire may have resulted in the 
questionnaire counting a cycle when the participant was enrolled in the study but did not 
have sexual intercourse during the fertile period. In such a situation, the participant 
would have rightly subtracted one cycle from her TTP. 
In assessing recall error of TTP, this study has some limitations. Prospectively-
measured TTP was calculated from the LMP date on the baseline and follow-up 
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questionnaires, and participants recalled these dates. The LMP date should be recalled 
highly accurately by someone planning pregnancy. Defining TTP as a rounded number of 
months created some measurement error because TTP in months is an inherently 
continuous measure. 
There are limits to generalizability because certain features of the present study 
may have aided in recall. First, the participants completed questionnaires during their 
pregnancy attempt, which may have improved recall accuracy compared to the recall 
accuracy from a pregnant mother in a retrospective study of fecundability. Second, the 
recall interval was very short, and recall accuracy may be greater for TTP recalled earlier 
in pregnancy. Third, this was by design a study of participants who became pregnant 
within :S12 months, and the median TTP was 2 months. This limits the ability to describe 
error in recalled TTP for a wider range of TTPs since longer attempt times tend to have 
greater recall error. Therefore, the estimates of error in this study may be viewed as the 
"best case scenario" for the extent of the recall error in TTP. 
In conclusion, mothers in the first trimester of pregnancy who had conceived in 
:S12 months recalled their TTP in months with little error, on average. There was greater 
under-estimation of retrospectively-measured TTP among women with a prospectively-
measured TTP >2 months as compared with :S2 months and among women with irregular 
relative to regular menstrual cycles. Because this study included participants in a 
prospective study of TTP and assessed recall in the frrst trimester, recall error may have 
been less than it is in retrospective studies of TTP, particularly those that enroll 
participants late in pregnancy. We demonstrated the feasibility in conducting a 
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quantitative bias analysis to assess the impact of recall error on the bias and precision of 
the effect estimate. 
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Table 15. Characteristics of 425 women who recalled their time-to-pregnancy in the first 
trimester: The Snart-Gravid Study, Denmark, 2007-2012. 
Characteristic 
Gestational age, weeks (median) 8 
Age <30 (%) 62 
Body mass index, kg/m2 (%) 
<20 17 
20-24 57 
25-29 20 
~30 6 
Regular cycles (%) 80 
Last method of contraception (%) 
Oral contraceptive pills 58 
Barrier methods 34 
Othera 8 
Gravid (%) 4 7 
Parous(%) 39 
Current smoker (%) 12 
a Includes withdrawal and fertility awareness methods. 
Table 16. Frequency distribution of retrospectively-measured time-to-pregnancy conditional on 
prospectively-measured time-to-pre~nancy in 421 women: The Snart-Gravid Study, Denmark, 2007-2012. 
Prospectively-measured time-to-pregnancy, months 
Total 
1 2 3 4 5 6 7 8 9 10 11 12 > 12 
106 28 2 2 1 0 0 0 0 0 0 0 0 139 
~ ('!) 
2 29 37 14 2 1 2 1 0 0 0 0 0 0 86 ..... ..... 
0 
en 
"0 3 1 18 30 19 5 3 0 0 1 0 0 0 0 77 ('!) 0 
..... 
~-
4 0 0 10 16 6 6 0 1 0 1 0 0 0 40 ('!) 
-< I 
3 5 0 0 4 3 14 6 1 0 0 0 0 0 0 28 ('!) 
P> 
en 
~ 6 0 0 1 3 5 9 1 1 1 0 0 0 0 21 ..... ('!) 
0.. 
::t. 7 0 0 0 0 1 3 4 2 0 0 0 0 0 10 1.0 a +:>-
('!) 
I 
..... 8 0 0 0 0 0 1 2 3 1 0 1 0 0 8 0 
I 
"0 
..... 
('!) 9 0 0 0 0 0 0 1 1 1 0 0 0 0 3 (Jq 
::l § 10 0 0 0 0 0 0 0 0 0 2 5 0 0 7 0 
::=:: 
a 
0 
11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
::l 
..... 
::r- 12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
"' 
>12 0 0 0 1 0 0 0 0 0 1 0 0 0 2 
Total 136 83 61 45 33 30 10 8 4 3 6 0 0 421 
Table 17. Error in recalled time-to-pregnancy: 421 women in the first trimester, Snart-Gravid, Denmark, 2007-2012. 
Recall Error, monthsc Recall Error, % of prospective TTPd 
%Under- %Over- Mean 
estimated" estimatedb Mean Difference Mean Difference 
N ~95% Cl! ~95% CI! Mean ~95% CI! ~95% CI2 ~95% Cl! ~95% CI! 
Entire population 421 27 (23, 31) 20 (16, 24) -0.11 (-0.25, 0.04) -- 4 (0, 8) 
Prospective TTP 
::;2 219 13 (8, 17) 22 (16, 27) 0.10 (0.02, 0.18) 0 (reference) 12 (6, 17) 0 (reference) 
>2 202 43 (36, 49) 18 (13, 24) -0.33 (-0.62, -0.03) -0.42 (-0.73 , -0.11) -5 (-11, 1) -17(-25,-8) 
Cycle Regularity 
Regular 337 26 (22, 31) 22 (18, 27) -0.06 (-0.23 , 0.12)) 0 (reference) 6(1,11) 0 (reference) 
Irregular 84 30 (20, 40) 12 (5, 19) -0.31 (-0.55, -0.07) -0.25 (-0.55, 0.05) -7 (-13, 0) -13 (-21, -5) 
Age 
<30 259 24 (19, 29) 20 (14, 27) -0.11 (-0.23, 0.02) 0 (reference) 4 (0, 9) 0 (reference) 
230 162 32 (25, 39) 20 (14, 27) -0.10 (-0.44, 0.02) -0.003 (-0.36, 0.35) 2(-6,11) -2 (-8, 11) \0 Vl 
Gravidity 
Nulligravid 221 27 (21, 33) 22 (16, 27) -0.10 ( -0.22, 0.03) 0 (reference) 4 (-1, 8) 0 (reference) 
Gravid 200 27 (21, 33) 19 (13, 24) -0.12 (-0.40, 0.16) -0.02 (-0.28, 0.33) 4(-3,11) 0(-9,9) 
Last contraceptive 
method 
Barrier methods 139 25 (18, 32) 16 (10, 22) -0.03 ( -0.40, 0.35) 0 (reference) 3 (-6, 12) 0 (reference) 
Oral contraceptive 247 26 (20, 31) 25 (19, 30) -0.07 (-0.20, 0.07) -0.04 ( -0.36, 0.28) 7 (2, 12) 4 (-5, 13) 
Othere 35 51 (35; 68) 3 (0, 8) -0.68 ( -1.0, -0.35) -0.66 ( -1.23 , -0.07) -19 (-30, -8) -22 (-39, -6) 
"Under-estimated by 21 month 
hOver-estimated by 21 month 
cRecall error in months calculated as follows: Recalled TTP- Prospective TTP 
dRecall error, percent of prospective TTP calculated as follows: 100%*[ (Recalled TTP-Prospective TTP) I (Prospective TTP)] 
e Includes rhythm method, withdrawal, and other. 
Table 18. Error in recalled time-to-pregnancy: 396 women in the first trimester with maximum interval<3 menstrual cycles 
between filling out guestionnaires, Snart-Gravid, Denmark, 2007-2012. 
Recall Error, monthsc Recall Error, % of prospective TTPd 
%Under- %Over- Mean 
estimated• estimatedb Mean Difference Mean Difference 
N (95% CI) (95% CI) Mean (95% CI) (95% CI) (95% CI) (95% CI) 
Entire population 396 26 (21, 30) 20 (16, 24) -0.09 (-0.22, 0.04) -- 4 (0, 9) 
Prospective TTP 
::;2 214 13 (8, 17) 21 (16, 27) 0.09 (0.01, 0.17) 0 (reference) 12 (6, 18) 0 (reference) 
>2 182 41 (34, 48) 18 (13, 24) -0.30 (-0.58, -0.03) -0.40 ( -0.68, -0.11) -4 (-11, 2) -16 (-25, -8) 
Cycle Regularity 
Regular 316 25 (20, 29) 22 (18, 27) -0.03 (-0.19, 0.12) 0 (reference) 7 (2, 12) 0 (reference) 
Irregular 80 29(19,39) 11 (4, 18) -0.30 ( -0.54, -0.06) -0.26 (-0.55, 0.02) -7 (-13, 0) -14 (-22, -6) 
Age 
<30 242 22 (17, 28) 19 (14, 24) -0.07 (-0.18, 0.05) 0 (reference) 5 (0, 10) 0 (reference) '-0 0\ 
2:30 154 31 (23, 38) 21 (14, 27) -0.12 (-0.42, 0.17) 0.06 (-0.26, 0.37) 3(-5,11) -2 (-12, 7) 
Gravidity 
Nulligravid 210 26 (20, 32) 21 (16, 27) -0.08 (-0.20, 0.05) 0 (reference) 4 (-1, 9) 0 (reference) 
Gravid 186 25 (19, 31) 18 (13, 24) -0.10 (-0.35, 0.15) 0.02 (-0.24, 0.29) 5 (-1, 12) 1 (-8, 10) 
Last contraceptive 
method 
Barrier methods 133 23 (16, 30) 15 (9, 21) -0.08 (-0.41, 0.24) 0 (reference) 3 (-6, 12) 0 (reference) 
Oral contraceptive 229 23 (18, 29) 25 (20, 31) -0.02 (-0.14, 0.10) 0.06 (-0.22, 0.35) 8(3, 14) 5 (-4, 14) 
Othere 34 50 (33, 67) 3 (0, 9) -0.58 (-0.86, -0.32) -0.50 (-1.00, 0.002) -18 (-29, -7) -21 ( -38, -5) 
•under-estimated by 2:1 month 
hOver-estimated by 2:1 month 
cRecall error in months calculated as follows: Recalled TTP- Prospective TTP 
dRecall error, percent of prospective TTP calculated as follows: 100%*[ (Recalled TTP-Prospective TTP) I (ProspeCtive TTP)] 
e Includes rhythm method, withdrawal, and other. 
Table 19. Error in recalled time-to-pregnancy: Sensitivity analysis in 172 women in the first trimester with maximum 
interval<2 menstrual cycles between filling out questionnaires, Snart-Gravid, Demnark, 2007-2012. 
Recall Error, monthsc Recall Error, % of %Under- %Over- prospective TTPd 
estimated" estimatedb Difference Mean (95% Difference 
N (95% CI) (95% CI) Mean (95% CI) (95% CI) CI) (95% CI) 
Entire population 172 23 (16, 29) 17 (11 , 22) -0.14 (-0.29, -0.002) -- 4 (-3, 10) 
Prospective TTP 
:::;2 103 17(9,24) 21 (23, 29) 0.06 (0.07' 0.18) 0 (reference) 13 (3, 22) 0 (reference) 
>2 69 32 (21, 43) 10 (3, 17) -0.44 (-0.75, -0.15) -0.51 (-0.79, -0.22) -9 (-15, -3) -22 (-33 , -10) 
Cycle Regularity 
Regular 119 19 (12, 26) 20 (13 , 27) -0.04 (-0.19, 0.10) 0 (reference) 9 (1 , 18) 0 (reference) 
Irregular 53 30 (18, 43) 9 (2, 17) -0.38 (-0.72, -0.04) -0.26 (-0.55, 0.02) -9 (-17, 0) -18 (-30, -6) 
Age 
<30 104 18 (11, 26) 15 (8, 22) -0.10 (-0.27, 0.08) 0 (reference) 6 (-2, 15) 0 (reference) 
2:30 68 29(19, 40) 19 (10, 28) -0.22 ( -0.46, 0.02) -0.12 (-0.42, 0.18) 0 (-10, 10) -6 (-7, 19) 
Gravidity 
Nulligravid 82 23 (14, 32) 18 (10, 27) -0.05 (-0.22, 0.13) 0 (reference) 6 (-4, 17) 0 (reference) 
Gravid 90 22 (14, 31) 16(8, 23) -0.23 (-0.46, -0.009) -0.18 (-0.47, 0.10) I (-7, 10) -5 (-18, 8) 
Last contraceptive 
method 
Barrier methods 68 21 (11 , 30) 13 (5, 21) -0.20 (-0.47, 0.06) 0 (reference) 0(-9,9) 0 (reference) 
Oral contraceptive 85 20 (11, 29) 22 (13 , 31) -0.03 ( -0.22, 0.15) 0.17 ( -0.13 , 0.48) 11(0,21) 11 (-3, 24) 
Othere 19 42 (20, 64) 5 (0, 15) -0.42 ( -0. 75 , -0.09) -0.22 (-0.70, 0.27) -14 (-31 , 4) -14 (-35, 8) 
"Under-estimated by 2:1 month 
hOver-estimated by 2:1 month 
cRecall error in months calculated as follows: Recalled TTP- Prospective TTP 
dRecall error, percent of prospective TTP calculated as follows : 100%*[ (Recalled TTP- Prospective TTP) I (Prospective TTP)] 
e Includes rhythm method, withdrawal, and other. 
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Table 20. Percentage distribution of prospective time-to-pregnancy conditional on 
retrospective time-to-pregnancy in 386 women: The Snart-Gravid Study, Denmark, 2007-
2012.a ' 
Prospective time-to-pregnancy, months 
1 2 3 4 5 6 7 8 9 10 11 12 >12 
1 79 17 2 1 1 0 0 0 0 0 0 0 0 
2 36 45 13 1 1 3 1 0 0 0 0 0 0 
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a Probabilities are presented as row percentages. 
Table 21. Fecundability differences by last contraceptive method: oral contraceptive pills (247 women) versus barrier methods 
{139 womenl, Snart-Gravid Cohort, Denmark, 2007-2012. 
Prospective 
Month Difference 95%CI 
1 
-0.13 -0.23 
2 0.00 -0.11 
3 -0.03 -0.18 
4 0.07 -0.10 
5 -0.13 -0.34 
6 . 0.04 -0.24 
TTP, time-to-pregnancy 
CI, confidence interval 
-0.04 
0.12 
0.11 
0.23 
0.08 
0.32 
Retrospective 
Difference 95%CI 
-0.20 -0.29 -0.10 
0.00 -0.12 0.12 
-0.07 -0.22 0.09 
-0.03 -0.23 0.17 
0.06 -0.18 0.29 
-0.01 -0.32 0.29 
100,000 Simulations 
95% 95% 
Difference a simulation simulation 
intervalb intervale 
-0.15 -0.21 -0.09 -0.27 -0.03 
-0.10 -0.20 -0.01 -0.25 0.05 
-0.05 -0.17 0.08 -0.25 0.15 
-0.05 -0.20 0.10 -0.29 0.20 
-0.03 -0.23 0.16 -0.34 0.27 
-0.05 -0.27 0.20 -0.44 0.34 
a Median value of the cycle-specific fecundability differences calculated in 100,000 simulated data sets. 
b 2.51h percentile and 97.51h percentile of the cycle-specific fecundability differences calculated in 100,000 simulated data sets. 
c 2.51h percentile and 97.5th percentile of the cycle-specific fecundability differences with random error from retrospective TTP 
analysis added, calculated in 100,000 simulated data sets. 
'D 
'D 
100 
Table 22. Frequencies of time-to-pregnancy in months: compare observed prospective 
values from N=384 women with Monte Carlo estimates from 100,000 simulations. 
Percent 
TTP, Prospective 100,000 
months value data sets 
1 32.55 32.55 
2 19.27 19.28 
3 14.58 14.58 
4 10.68 10.68 
5 7.55 7.54 
6 7.81 7.81 
7 2.34 2.34 
8 1.82 1.83 
9 1.04 1.06 
10 0.78 0.81 
11 1.56 1.56 
Total 100.00 100.00 
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Figure 6. 
Cumulative percent pregnant by month: 421 women who conceived in :S12 months, 
Snart-Gravid Study, Denmark, 2007-2012. 
Cumulative Percent Pregnant: First Trimester, omit outliers (N=42 1) 
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Figure 7. 
Cumulative percent pregnant by month: 398 women who conceived in :Sl2 months and 
responded to questionnaires in <3 menstrual cycles, Snart-Gravid Study, Denmark, 2007-
2012. 
Cumulative Percent Pregnant: First Trimester, <3 Cycles (N=398) 
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Figure 8. 
Cumulative percent pregnant by month: 173 women who conceived in :S12 months and 
responded to questionnaires in <2 menstrual cycles, Snart-Gravid Study, Denmark, 2007-
2012. 
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5. CONCLUSIONS 
Among Danish women, 20% are regular smokers (1) and 49% permit smoking in 
the home (2). The prevalence of birth by CS has increased in Denmark (3), due at least in 
part to an increasing number of patients who need it. Greater numbers of mothers are 
overweight (4) or of advanced maternal age (5), both risk factors for CS. Also, 
improvements in care for infertility and obstetric complications enable viable pregnancies 
in vulnerable patients who need added surveillance and intervention to protect the health 
of mother and child. Little is known about possible lasting effects on reproduction from 
active smoking, passive smoking, and CS. Also, most fecundability studies use a 
retrospective design, and researchers have assessed error in retrospective TTP and its 
impact on the validity and precision of study results. These assessments were limited by 
the lack of a completely prospective measure ofTTP for comparison. We sought to fill 
current gaps in knowledge by using detailed, accurate data on these exposures, potential 
confounders, prospective TTP, and retrospective TTP, from the Snart-Gravid study and 
the Danish Medical Birth Registry. 
Study 1 found that duration and pack-years of smoking were associated with 
reduced fecundability in both current and former smokers relative to never smokers. 
Among never smokers, passive smoking in early life and adulthood were not appreciably 
associated with fecundability. In Study 2, emergency CS with cephalic presentation was 
not associated with fecundability, after adjusting for predisposing factors for CS, among 
women attempting to conceive their second child. Elective CS with cephalic presentation 
and CS with breech presentation were inversely associated with fecundability. Study 3 
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found that there was a small amount of error in retrospective TTP recalled in the first 
trimester, compared to prospective TTP. Prospective TTP >2 and irregular cycle length 
were associated with greater negative recall error. Recall error did not vary meaningfully 
by maternal age, gravidity, or last contraceptive method. The error in retrospective TTP 
did not change the estimated association between last contraceptive method and 
fecundability enough to change the conclusion about the magnitude of the association. 
Simulation intervals from a quantitative bias analysis conveyed the increase in 
uncertainty around the association by incorporating systematic and random error. 
Our results have implications for further research and clinical practice. Other 
fecundability studies with detailed information on smoking history will be able to further 
investigate the extent of the hazards to fecundability from cumulative exposure to active 
and passive smoking. If confirmed, this result provides further motivation to quit to 
women who have been smoking for a long time, and who may have previously failed to 
quit. For estimating the association of current exposure to passive smoking with 
fecundability, cotinine concentration in the urine or follicular fluid would be a more 
accurate measure of exposure. Prospective studies that enroll couples before their first 
birth and collect data on pregnancy planning, medical diagnoses, and fecundability both 
before and after the first pregnancy, will be better able to definitively assess the relation 
between CS for first birth and future fecundability. Finally, our measure of recall error 
and demonstrated bias analysis may be useful for investigators on studies that collect 
retrospective TTP in the first trimester. Recall error after several years is also of interest 
and could be measured with additional follow-up of our study participants. 
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6.1 APPENDIX 1. 
Potential confounders of caesarean and TTP from literature review 
(* indicates would be controlled by restricting to primigravidas) 
Female: 
Age (birth year, age at first birth) 
Lifestyle habits: 
--alcohol intake 
--cigarette smoking 
--physical activity (moderate and vigorous) 
Current health conditions and habits: 
--Body mass index 
-- last method of contraception 
--intercourse frequency 
--timing intercourse for fertile window 
Reproductive history: 
--Sex of first child 
--Hx PID 
--Hx Infertility 
--Birth weight of first infant 
--Hx miscarriage* 
--Hx ectopic pregnancy* 
P . * -- anty 
--Gravidity* 
--Irregular cycles 
--cycle length 
--Age at menarche 
Socioeconomic Position: 
--education 
Male Factors: 
Age (birth year) 
Continued on next page ... 
Appendix 1, continued ... 
Complications of first pregnancy: 
--multiple gestation 
--gestational weight gain 
--genital herpes 
--polyhydramnios, oligohydramnios 
--pregnancy-induced hypertension 
--pre-existing hypertension 
--pre-eclampsia 
--diabetes (pre-existing, gestational) 
--incompetent cervix 
--uterine bleeding 
--Rh sensitization 
--hemoglobinopathy 
--preterm delivery 
Complications of delivery: 
--cephalopelvic disproportion 
--birth weight >4000g 
--placenta previa 
--placenta abruptio 
--cord prolapse 
--prolonged or dysfunctional labor 
--maternal fever 
--fetal distress 
--premature rupture of membranes 
--excessive bleeding 
--meconium (moderate, heavy) 
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6.2 APPENDIX 2. 
Variables in the model for propensity score of each category of caesarean section. 
Variable 
Maternal age at first birth 
Maternal BMI 
Pack-years of smoking 
Fetopelvic disproportion 
Placental abruption 
Post-term delivery 
Preterm delivery 
Birthweight <2,500g 
Birthweight ~4,000 g 
Abnormal condition of 
the fetus 3 
Placenta previa 
PPROMb 
Hypertensive disorderc 
Diabetes 
Thyroid disorder 
Uterine fibroids 
Mullerian anomaly 
History of infertility 
Intensity of menstrual 
flow 
Last method of 
contraception 
Caesarean section, 
breech presentation 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Emergency 
caesarean section, 
cephalic 
presentation 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Elective caesarean 
section, cephalic 
presentation 
X 
X 
X 
X 
X 
X 
X 
X 
Frequency of intercourse X X X 
a Includes pregnancy with rhesus isoimmunization, other abnormal condition of the fetus. 
b PPROM, preterm premature rupture of membranes. 
c Includes preeclampsia, eclampsia, pre-existing hypertension, pregnancy-induced hypertension 
without proteinuria, pregnancy-induced proteinuria without hypertension. 
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